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iiiAbstract
Several studies suggest that the use of ultrasound in conjunction with microbubbles (MBs) can
induce the lysis of the blood clots through acoustic cavitation and through the production of
microjets and microstreaming. However, there is no accordance about the optimal ultrasound
parameters that have to be considered in order to achieve the maximum thrombolytic e￿ect, neither
a clear agreement about the type of MBs that have to be used.
This project had two main goals: the design and optimization of an in-vitro set-up for the
study of clot lysis within coronary arteries and its testing with ultrasound in conjunction with two
di￿erent types of MBs. The MBs considered were the 3MiCRON MBs and the SonoVue MBs.
The ultrasound sequence was developed using a programmable ultrasound architecture (Vera-
sonics, Inc) and was tested using commercially available clinical transducers.
Using the designed set-up and varying the ultrasound parameters (frequency, pulse length and
pulse amplitude) it was possible to study the clot lysis e￿ciency in conjunction with the two types of
MBs. For the 3MiCRON MBs no increase in clot lysis was found with the implemented ultrasound
parameters, while considering the SonoVue MBs, a 10% increase in clot lysis was found with 10ms
long pulse delivered at 50V (peak-to peak value).
The obtained set-up had several aspects in common with the real situation of occluded coronary
arteries, although some limitations were present and further optimizations are required.
Further work is required in order to assess if di￿erent combination of ultrasound parameters are
able to lead to an increase in clot lysis when delivered with 3MiCRON or SonoVue MBs.
iiiivSommario
Diversi studi suggeriscono che l’utilizzo di ultrasuoni e di microbolle (agenti di contrasto) pu￿
indurre la lisi di trombi sanguigni attraverso il fenomeno della cavitazione acustica e tramite la
produzione di microgetti e microvortici. Tuttavia, non vi Ł un comune accordo su quali siano i
parametri ultrasonori ottimali nŁ le microbolle da utilizzare al ￿ne di ottenere il massimo e￿etto
trombolitico.
Questo lavoro di tesi presenta due obiettivi fondamentali: la progettazione ed ottimizzazione di
un sistema in-vitro per lo studio della lisi dei trombi all’interno delle arterie coronarie e l’utilizzo di
tale sistema in concomitanza con l’applicazione di ultrasuoni e di microbolle. Due tipi di microbolle
sono state prese in esame: 3MiCRON e SonoVue.
La sequenza di onde ultrasonore Ł stata sviluppata tramite un’architettura programmabile (Ve-
rasonics, Inc) ed Ł stata trasmessa usando trasduttori clinici presenti in commercio .
Utilizzando il sistema sviluppato e variando i parametri ultrasonori (frequenza, lunghezza e
ampiezza dell’impulso) Ł stato possibile studiare l’e￿cienza trombolitica degli ultrasuoni con i due
tipi di microbolle. Applicando le microbolle 3MiCRON non Ł stato riscontrato alcun miglioramento
nella lisi dei trombi, mentre considerando le microbolle SonoVue Ł stato notato un aumento della
trombolisi del 10%, trasmettendo impulsi ultrasonori della durata di 10ms a 50V (valore picco-
picco).
Il sistema progettato ha diversi aspetti in comune con la situazione reale di occlusione delle
arterie coronarie, sebbene siano presenti alcune limitazioni e ulteriori studi di ottimizzazione siano
necessari.
Studi aggiuntivi sono inoltre necessari al ￿ne di chiarire se diverse combinazioni di parametri
ultrasonori siano capaci di condurre ad un aumento della trombolisi in combinazione con i due tipi
di microbolle considerati.
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ixx IntroductionIntroduction
Vascular thrombosis is the formation of clots of di￿erent sizes within the vessels. The treatment
of this disease can be done pharmacologically or through an intravascular device (e.g. in￿atable
balloon), but both of these strategies produce serious shortcomings such as bleeding (e.g. intrac-
erebral hemorrhage in the treatment of ischemic stroke) and blood vessels damage. Moreover, they
do not achieve optimal reperfusion of the microvasculature.
Several studies suggest that the use of ultrasound can induce the lysis of the clots through
acoustic cavitation and through the production of microjets and microstreamings. This application
of US for the treatment of clots and for their reduction is de￿ned as sonothrombolysis.
In addition, intravenously injected microbubbles (MBs) combined with ultrasound can further
improve thrombolysis, lowering the cavitation threshold.
There is no accordance about the optimal ultrasound parameters that have to be considered
in order to achieve the maximum thrombolytic e￿ect, neither a clear agreement about the type of
MBs that have to be used. This is due to the unclear process of cavitation and rather unde￿ned
dynamics of MBs within and around the clots.
Aim of the Project
This project had two main goals:
1. The ￿rst goal was to design an e￿cient in-vitro set-up that enabled the study of the e￿ects of
ultrasound waves and MBs in the treatment of occluded vessels. The set-up had to reproduce
the physiological situation of thrombosis in the coronary arteries and to allow estimation of
sonothrombolysis e￿ciency. To achieve these aspects, optimization and validation processes
were performed in order to obtain a set-up as reliable as possible.
2. The second goal was to assess the ability of MBs to improve sonothrombolysis in conjunction
with a speci￿c sequence of ultrasound pulses delivered using linear transducers. In particular,
a novel type of MBs, developed within the framework of the european project 3MiCRON,
was studied in order to assess its capacity to enhance the thrombolysis. These new MBs
were compared with commercially available SonoVue bubbles. The ultrasound sequence was
developed using a programmable ultrasound architecture that enabled to study and to im-
plement algorithms with variable ultrasound parameters such as frequency, pulse length and
amplitude.
xixii Introduction
Structure of the work
Chapter 1: the de￿nition of thrombus is given together with the di￿erent types of disease that
can cause. For each type of disease the actual treatments are also presented. In addition,
a brief description of ultrasound principles and physics is presented together with a brief
introduction to contrast agents and their use in ultrasound. Moreover, sonothrombolysis is
de￿ned together with its mechanisms of action, safety aspects and the di￿erent techniques of
ultrasound delivery for clot lysis.
Chapter 2: the methods and the results for the design, optimization and validation of the in-vitro
set-up are described.
Chapter 3: the methods and the results of the tests with ultrasound in conjunction with MBs are
presented. All the tests were performed using the in-vitro set-up obtained after optimization
and validation processes. Moreover, in this chapter, a description of the Verasonics system
and of the implemented algorithm is provided.
Chapter 4: the results obtained are analyzed and discussed. In addition, a conclusion with study
limitations and future developments is presented.
The MatLab code for pulse sequences programmed with Verasonics is given as an appendix.Chapter 1
Background
1.1 Thrombosis
Ischemic heart disease and stroke, induced by vascular thrombosis, are the major causes of death
in the high-income countries [1].
Normally, cardiovascular system maintains equilibrium between anticoagulant and procoagulant
state. The ￿rst state is very important for the cells on the endothelium, whereas the second state
is important when vessel damage occurs.
Anticoagulation is necessary for maintaining normal blood ￿uidity and is regulated by agents
released by endothelial cells. These agents, called anticoagulant factors, are proteins able to interfere
with the clotting process.
In the procoagulant state it is possible to distinguish two pathways that converge in a common
pathway and lead to the formation of ￿brin, a protein involved in blood clotting. These pathways
are a serious of reactions during which speci￿c enzymes are activated (they normally circulate in-
activated) in a cascade-like behavior. These activated enzymes, called coagulation factors, catalyze
di￿erent reactions leading to the formation of ￿brin. The ￿rst pathway is the extrinsic one, which
occurs when an injury to a blood vessel is present and is started by a particular protein called tissue
factor. This factor activates several reactions until a factor named X, necessary for the common
pathway, is activated. On the other side, the intrinsic pathway starts when contact between speci￿c
proteins and a negatively charged surface, such as bacteria surface, occurs. Again, similar reactions
as in the extrinsic pathway follows leading to the activation of factor X. Factor X is the ￿rst en-
zyme of the common pathway, which leads to the release of thrombin, allowing the conversion of
￿brinogen (a glycoprotein) in ￿brin. The latter is the main constituent of blood plug and is the
￿nal result of the coagulation process.
When the equilibrium between procoagulant and anticoagulant states is damaged, pathological
states occur. On one side, inadequate procoagulant state lead to the leakage of blood form the
vascular system. On the other hand overactive coagulant state may lead to thrombosis and blood
￿ow interruption.
A thrombus is an intravascular coagulation of blood with a site-dependent composition of ￿brin,
platelets, erythrocytes, leukocytes and serum [2]. Thrombus in arterial circulation contains a higher
concentration of platelets, whereas venous thrombus is rich in ￿brin. When a thrombus does not
contain ￿brin, it is called blood clot. Clots are made only of cells and they are more instable
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and fragile than thrombi. Thrombus is in general produced in the intravascular site and it is the
result of the coagulation cascade and the aggregation of platelets on the side of a vessel, while
clots are semisolid mass that are the result of only the coagulation cascade. For example, clots
can be obtained when blood is let to coagulate in a vial. Both thrombi and clots can be further
distinguished in white (arterial) or red (venous), depending whether the coagulation processes (and,
in the case of thrombus formation, the platelets aggregation) occur within arterial or venous blood.
Within the intravascular site, each of the two types of thrombi, arterial and venous, can lead to
di￿erent diseases.
If the thrombus breaks down, the small fragments can travel within the circulation leading to
the formation of emboli, which can obstruct vessels and produce tissue necrosis far away from
the thrombus formation site. In the subsequent session a brief description of di￿erent vascular
thrombosis and their current treatments will be presented.
1.1.1 Arterial Thrombosis
Arterial thrombosis is the formation of thrombi in arteries and is characterized by high concentra-
tions of platelets aggregates. Usually, it occurs in the presence of high blood ￿ow and many studies
have shown that arterial thrombi are caused by damage in the atherosclerotic plaques, which are
formed by release of procoagulant factors [3].
1.1.1.1 Coronary circulation and myocardial infarction
The coronary circulation, which is responsible for the supply of blood to the heart muscle, originates
from the root of the aorta and it is structured in right and left coronary arteries. The right coronary
artery is responsible for sending the blood to the right atrium and right ventricle. In analogy, the
left coronary artery supplies the left atrium and left ventricle with blood. Furthermore, the left
coronary artery is divided in left circum￿ex artery and left anterior descending artery [2] (Figure
1.1). The latter one is the most a￿ected by emboli during coronary circulation disease [4]. The
coronary arteries (approximately 4mm in diameter) are subdivided in smaller vessels until they
reach the size of a capillary network (40 mm), which penetrate in the tissue and allow the exchange
of oxygenated blood to the heart cells.
The amount of cardiac output that goes into the coronary circulation is 5% and the provided O2
is used for oxidative processes and production of energy. Reduced oxygen supply for long periods,
due to obstructions, can lead to myocardial necrosis (myocardial infarction). However, collateral
blood vessels (originating from existing vessels through remodeling processes) may moderate the
reduced ￿ow, diminishing tissue damage. Nevertheless, collateral ￿ow may be not su￿cient and the
patient may feel pain in the chest (angina pectoris).
In order to treat patients with coronary artery disease, di￿erent ￿brinolytic agents can be admin-
istered. Some examples of ￿brinolytic agents are: tissue plasminogen activator (t-PA or recombinant
rt-PA when manufactured using recombinant biotechnology), urokinase-type plasminogen activator
(u-PA) and streptokinase.
When the drug delivery is not su￿cient or cannot lead to a total reperfusion, mechanical proce-
dure for revascularization may be necessary. Examples of this technique are coronary artery bypass
grafting and transluminal angioplasty. The latter procedure requires the use of an in￿atable bal-
loon, inserted using a balloon-tipped catheter. These techniques are used mostly for the treatment
of plaques, which are lesions within arteries. Plaques are characterized by accumulation of lipids1.1. THROMBOSIS 3
Figure 1.1: Coronary arteries [2]
and ￿brous elements and the activation process is started by alteration of the endothelium and ac-
tivation of the in￿ammatory process [5, 6]. Plaques can become complex, growing and obstructing
the blood ￿ow. In this situation, mechanical procedures are used in order to ￿atten the plaque and
restore blood ￿ow [2]. However, clinical complications are most likely to occur when a plaque is
disrupted and leads to acute occlusion due to thrombus formation.
Both pharmacological and mechanical treatments have low e￿ciency and can lead to dangerous
side e￿ects such as hemmorrage and blood vessels damage. Moreover, in the treatment of myocardial
infarction, these two methods often do not achieve reperfusion. This is because the principle aim
of these techniques is to restore the patency of the vessel and not the reperfusion. With the term
￿patency￿ is meant the quantity of vessels that are unoccluded after the treatment (including also
the vessels that were not completely obstructed before treatment), while the term ￿reperfusion￿
indicates the restored tissue perfusion within the myocardium [7]. A lack in reperfusion leads to
disorganization of capillary structures, swelling and edema. All these processes converge to the
phenomenon of no-re￿ow that leads to the impossibility of late recovery because pharmacological
agents are not able to reach the area [8]. Moreover, small particles may be produced within the
infarcted area and obstruct small arteries and arterioles downstream.
Di￿erent studies have demonstrated that sonothrombolysis is a therapeutic technique that can
achieve clot lysis and myocardial reperfusion and that ultrasound combined with MBs can treat the
infarcted zone even if the upstream artery remains occluded [9]. The mechanisms that are thought
to be responsible for the reperfusion with this technique are the triggering of collateral perfusion
and lysis of microemboli [9].
1.1.1.2 Ischemic Stroke
Another consequence of arterial thrombosis is ischemic stroke, during which the blood supply to the
brain is interrupted and brain cells do not receive the substances for maintaining their function. The4 CHAPTER 1. BACKGROUND
interruption of blood ￿ow arises from clots stopping in cerebral vessels after they have travelled
long distances [10]. When the blood supply to the brain is compromised, the ischemic cascade
occurs, which is a sequence of events at cellular level that governs the progressive cells death. In a
patient a￿ected by an ischemic stroke it is possible to distinguish a zone of death cells surrounded
by hypoperfused tissue called penumbra zone [11](Figure 1.2).
Figure 1.2: Ischemic area. Diagram of ischemic zones [12]
As for the myocardial infarction, thrombolytic agents can be used for the treatment of ischemic
stroke and the most used is rt-PA. However, several studies have shown that this technique leads to
intracerebral hemorrhage and bleeding [13]. Moreover, even without side e￿ects, the thrombolytic
treatment may be ine￿cient and clot may still obstruct the brain vessels [14].
In addition, it is important to underline that not all the patient with ischemic stroke can be
treated with thrombolytic agents because of di￿erent factors such as comorbidity and protocol
exclusions. Indeed, this type of drug must be administrated within three hours from symptom
manifestation and patients that have taken heparin in the previous 48 hours should not be treated
with thrombolytic therapy. Other reasons for exclusion are: another stroke in the previous three
months, surgery within the preceding 14 days, systolic blood pressure greater than 185 mm Hg or
diastolic blood pressure greater than 110 mm Hg [15].
1.1.1.3 Systemic embolism
Thrombus can be disrupted forming emboli, which are small particles that move within the blood
stream and can reach limbs occluding an organ extremity. This can be seen through imaging,
surgery or autopsy and it can occur in the absence of traumas or atherosclerosis.
1.1.2 Venous thrombosis
Venous thrombosis is the formation of thrombi in the veins and is characterized by high concen-
trations of ￿brin. The most common type of venous thrombosis is deep venous thrombosis. Other
types of venous thrombosis include portal vein, renal vein and cerebral venous sinus thrombosis.1.1. THROMBOSIS 5
1.1.2.1 Deep Venous thrombosis
Deep vein thrombosis occurs within the deep veins and is the most frequent form of venous throm-
bosis. Deep venous thrombosis usually originates from the veins of the calf and can be classi￿ed
in proximal and distal. Proximal deep venous thrombosis involves thigh veins, while the distal one
involves calf veins. Complication of this type of thrombosis can lead to venous valvular insu￿-
ciency, venous chronic obstruction and pulmonary embolism, which is the most common outcome
[16]. Pulmonary embolism is the obstruction of main artery in the lung. More than 90% of acute
pulmonary embolisms are caused by emboli produced in the proximal deep venous thrombosis [17].
The treatment of this type of thrombosis implies the use of heparin and warfarin derivatives,
which are anticoagulant drugs. This therapy prevents the propagation of the thrombus without
lysis of the existing one [18].
Another possible treatment is through catheter-based deliver of thrombolytic agents reducing
the post-thrombotic syndrome that may occur after a deep venous thrombosis manifestation and
may lead to chronic venous ulcerations, swelling and pain, which are caused mostly by damages to
venous valves [17].6 CHAPTER 1. BACKGROUND
1.2 Ultrasound principles
In this section a brief introduction to the ultrasound principles will be presented. The aim is not
to give an exhaustive description, rather an overview in order to better understand the subsequent
chapters and the project aim.
1.2.1 Ultrasound Physiscs
Ultrasound waves are sinusoidal mechanical perturbations with a frequency (number of vibrations
per unit of time) greater than 20kHz. In order to propagate, the ultrasound waves need a medium.
The molecules of the medium should not be too widely spaced like in gases, where the propagation
of the waves is strongly reduced. For this reason, in some bodies regions, such as lungs, the
ultrasound has poor e￿cacy. The propagation of ultrasounds occurs through consecutive phases of
compression and rarefaction along the propagation direction (Figure 1.3). Therefore, displacement,
velocity, pressure and acceleration of ultrasound can be described through a sinusoidal function,
characterized by a speci￿c frequency and wavelength.
Figure 1.3: Propagation of ultrasounds [19]
The elastic properties of the ultrasound waves in a medium are described by the following
Poisson’s equation:
P =  B
@U
@x
(1.1)
where P is the acoustic pressure, B is the elastic modulus and U is the displacement of the
particle around the equilibrium position. Combining the equation 1.1 with the equation of motion
for a particle, it is possible to ￿nd the relation between the elastic modulus, density and the velocity
of the wave, which is:
c =
s
B

(1.2)
with c being the velocity and  the density of the tissue. Therefore, low density and high
sti￿ness lead to high speed of sound.1.2. ULTRASOUND PRINCIPLES 7
The velocity of sound is assumed constant in all the soft tissues and equal to 1540m/s.
The energy transported in an ultrasound wave is usually characterized by an istantaneous acous-
tic intensity i(t) de￿ned as
i(t) =
p(t)2
c
(1.3)
with p(t) being the instantaneous pressure. From equation (1.3) it is possible to see that the
intensity increases with the pressure amplitude of the wave.
The ultrasound waves for diagnostic purposes (2-15MHz) are delivered through transducers
which may be linear or phased-array. The former are larger in size with rectangular ￿eld of view
and, due to the high frequencies used, they are suitable for near surface applications. The phased-
array transducers, instead, are smaller, with a sector ￿eld and they are more suitable for deeper
targets.
The delivery of ultrasound waves can be continuous or pulsed, where the latter is characterized
by sequences of pulses of speci￿ed duration spaced by an idle time. In this condition the important
parameters to consider are the pulse length and duty cycle. The latter is the percentage of time
that the ultrasound pulses are delivered as a fraction of the total time under consideration. Duty
cycle is correlated with the pulse repetition frequency, where the latter is the number of pulses per
unit of time. High values of pulse repetition frequency lead to high values of duty cycle.
1.2.2 Ultrasound interaction with tissue
When ultrasound wave propagates, it interacts with tissue through mainly three factors: re￿ection,
refraction and attenuation.
1.2.2.1 Re￿ection
Re￿ection is caused by an ultrasound wave travelling from a medium with impedance Z1 to another
medium with di￿erent impedance, Z2. Across the interface between the two media, part of the
acoustic energy is re￿ected back in the ￿rst medium. This type of interaction is very important
in image formation because the time point at which the returning signal occurs, gives information
about the position of the target within the body.
1.2.2.2 Refraction
When the direction of an ultrasound wave is not perpendicular to the target surface and there is
a change in the ultrasound speed between two di￿erent materials, part of the wave that is not
re￿ected passes through the boundary and changes the direction of the propagation leading to the
refraction e￿ect. When there is an increase in the velocity of the ultrasound wave from one medium
to the other the angle to the normal of the boundary surface also increases as described by the
Snell·s law:
sin#i
sin#t
=
c1
c2
(1.4)
where #i is the angle between the incident wave and the normal to the boundary, #t is the angle
between the transmitted wave and normal to the boundary, c1 is the velocity in the ￿rst medium
and c2 is the velocity in the second medium.8 CHAPTER 1. BACKGROUND
1.2.2.3 Attenuation
Attenuation is responsible for reducing the intensity of the ultrasound signal traveling through a
medium and is mainly caused by scattering and absortion.
For small targets the re￿ection laws are not valid due to the fact that, when the wave impacts
on such targets, it is scattered over a large range of angles. Therefore scattering phenomena lead
to changes in the sound direction of propagation.
Absorption is the conversion of the sound energy to other forms of energy. It is mainly caused by
molecular relaxation, which consists in the transformation of ultrasound energy in cellular energy
(e.g. heat). Each molecule has a speci￿c frequency of absorption and in biological tissue the ab-
sorption increases with frequency. The total attenuation coe￿cient a, which includes the previously
described factors, is given by
 :=
4I
I
4x
(1.5)
where x is the displacement and I is the intensity and it is given by:
I = I0e x (1.6)
with I0 being the initial intensity.
The attenuation coe￿cient of most tissues when expressed in dBcm 1 increases approximately
linearly with frequency. Therefore, when imaging deep organs a low frequency must be used,
whereas high frequency can only be used to image super￿cial targets.
1.2.3 Non linear propagation
When ultrasound waves are propagating in tissue, they generate echoes at foundamental frequency
f0 and at harmonic frequency (mostly at 2f0). The echoes at harmonic frequency vary with the
depth (Figure 1.4) and they are caused by non-linear propagation of ultrasound in the tissue, mul-
tiple re￿ections and tissue compressibility. To understand the harmonic generation it is important
to consider the ultrasound pressure wave. Indeed, the velocity of the ultrasound wave is higher in
the phase of compression, when the pressure is positive. This leads to a distortion (Figure 1.5) of
the transmitted wave that generates echoes with frequencies at multiple values of the transmitted
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Figure 1.4: Harmonic production with increasing depth
Figure 1.5: Distortion of ultrasound wave. A: wave not distorted B: distorted wave
In imaging mode, harmonics can allow deep penetration and higher resolution because the
transmission is at the frequency f0 and reception at the harmonic 2f0. In addition, the harmonics
generation occurs only if the value of the acoustic pressure is higher than a threshold, leading to
the reduction of some artifacts due to, for example, lateral lobes. Lateral lobes are caused by
ultrasound waves that propagate in other directions than the frontal one. However, the intensity
of such waves is too low to trigger the generation of the harmonics and therefore the signal is not
detected by the transducer.10 CHAPTER 1. BACKGROUND
1.2.4 Contrast agents
Non-linear propagation and harmonic generation may be enhanced with speci￿c contrast agents
composed by small (1-6￿m) encapsulated microbubbles (MBs), which are injected intravenously
and combined with speci￿c contrast sequences in order to enhance the ultrasound e￿ect. Several
types of MBs have been developed and in Table 1.1 some examples are listed.
Table 1.1: Characteristic of some contrast agents [19, 20].
AGENT DISTRIBUTION
AREA
TYPE OF
AGENT
SHELL GAS BUBBLE
SIZE
LEVOVIST Europe, Japan,
Canada
Lipid
stabilised
bubble
Palmitic Acid Air 3-5mm
SONOVIST development stage Solid
microspheres
Cyano-
acrylate
Air Mean 2mm
DEFINITY USA, Europe,
Canada
Encapsulated
bubble
Lipid Per￿uoropropane Mean 2mm
OPTISON USA, Europe,
Canada
Encapsulated
microsphere
Albumin Octa￿uoropropane Mean
3.7mm
SONOVUE Europe, China Stabilised
bubble
Phospholipids SF6 2-3mm
(90%<8mm)
SONAZOID not
commercialized
Information
not available
Surfactant
membrane
Fluorocarbon Median
3.2mm
ALBUNEX not
commercialized
Encapsulated
bubbled
Albumin Air Mean 4mm
(Range
2-10mm)
Early agents contained air and the coating was made of albumin (Albunex). Later, agents were
developed with a ￿uorinated gas core (Optison) or per￿uoropropane gas and protein shell (De￿nity).
The ￿rst air-￿lled MBs tend to collapse in saline and their weak shell decrease their ability to
cross the circulation of lungs. The latest MBs, which are lipid coated, are more stable in saline and
their size is consistent with the dimensions of the microcirculation.
The manufacturing process of MBs is done mostly by mechanical agitation and, after their
injection they circulate similarly to red blood cells for an interval of time that is of the order of
minutes. When the MBs are reached by ultrasound waves with speci￿c frequencies, their vibration
is enhanced, thus increasing the echo signal strength. MBs are strong scatterers and the maximal
enhancement of the echo signal occurs when the applied frequency is close to the resonance frequency
of the MBs. This resonance frequency has values close to the ones used in diagnostic ultrasound.
For example, the SonoVue MBs have a mean resonance frequency that ranges between 1-4MHz [21],
which is a typical range at which most of the clinical transducers work. Therefore, the use of these
MBs does not require changes of the ultrasound machines or transducers.
The pressure value of the incident waves is another important factor to consider when analyzing
the MBs interaction with ultrasound. For low peak rarefactional pressure (around 100kPa) the
oscillations of MBs corresponds to the rarefaction and compression of the ultrasound wave with a
frequency close to the incident ultrasound frequency. For higher peak rarefactional pressure the
oscillation of the MBs has a non-linear relationship to the driving pressure. The MBs expansion in1.2. ULTRASOUND PRINCIPLES 11
this case is no more sinusoidal and it is followed by a faster collapse. Rising even more, the peak
rarefactional pressure leads to the destruction of the MBs, with gas di￿using in the surrounding
space. When MBs collapse ￿uid jets are produced that can result in 16 ￿m wide pit in the surface
of cells [22].
The ￿rst imaging techniques that included dedicated contrast sequences for enhancing the sig-
nal from the MBs and suppressing tissue signal, were based on the detection of the harmonics
returned from each transmitted pulse. Each echo was received and ￿ltered in order to keep only
the harmonics. Later techniques involved the use of low-amplitude pulse trains which consists of
pulses with alternated phase, amplitude or both phase and amplitude. Summation of the returned
echoes cancels the linear component coming from the tissues while keeping MBs echoes. Harmonic
imaging with MBs has many applications in cardiology for the assessment of wall motion and per-
fusion defects and great interest is raising in MBs applications for targeted ultrasound imaging.
This technique involves the use of contrast agents having a ligand on the surface that binds to a
function-speci￿c molecule. This leads to persistent enhancement during imaging [23], enabling to
distinguish better the target area (where the contrast agent binds) from normal tissue.
Beside transmission frequency and peak rarefactional pressure, other important parameters are
pulse duration, time between destructive pulses, MBs concentration and size distribution. Pulse
has to be short during imaging for better axial resolution, which is the smallest distance between
two targets along the beam axis that enables to obtain two separable images. Therefore, short
pulses will lead to short echoes from the MBs improving the image resolution.
In case of destructive pulse delivery, the time between two pulses should be enough for bubbles
replenishment, allowing new bubbles to reach the area of interest and to be disrupted emitting
non-linear echoes.
In perfusion imaging it was seen that there is a strong dependence between signal intensity and
the size distribution and concentration of the contrast agent administered [24]. Increasing the MBs
concentration led to better imaging of the interested area until a saturation point is reached. For
higher concentration than the saturation value no improvement in image quality was seen. Also an
increase in MBs size led to better image quality through contrast enhancement.
In this project, two types of MBs were compared:
￿ SonoVue MBs. The SonoVue MBs (Bracco, Milan, Italy) contain sulphur hexa￿uoride,
which is a very stable molecule, without any interaction with other body molecules. The shell
consists of a phospholipidic membrane that is highly ￿exible, allowing the MBs to change the
size and shape. The mean size of these MBs is 2.5 mm and the resonance frequency ranges
between 1 and 4MHz [21].
￿ 3MiCRON MBs. The 3MiCRON MBs are air-￿lled MBs characterized by a polymeric
shell, which is much thicker and sti￿er than the SonoVue one. This leads to the need of high
pressure values for the bubble oscillation and shell rupture.The mean size of these MBs is
3mm and the resonance frequency is around 12MHz [25].12 CHAPTER 1. BACKGROUND
1.3 Sonothrombolysis
In the last years sonothrombolysis has become a very attractive alternative in the treatment of
thrombus and several studies were performed and are still ongoing in order to gain more knowledge
about the process of interaction between ultrasound waves and thrombi.
Investigations of the use of ultrasound in the lysis of thrombi located in di￿erent areas were
done in particular within brain, heart and peripheral arteries. The combination of ultrasund and
￿brinolytic drugs was also studied and the results showed that sonothrombolysis in these conditions
may be enhanced (40% increase in clot mass loss), leading to the reduction of the concentration of
rt-PA needed. In particular, the use of ultrasound and rt-PA enhance thrombolysis in vitro and in
vivo [26, 27, 28], accelerating the recanalization through the increase of the transport and uptake of
rt-PA into the thrombus. It is important to underline that the enhancement of the lysis is not due
to the speci￿c ￿brinolytic agent used. Indeed, in several studies, other anticoagulant drugs, such as
urokinase [29], were used and the results are comparable with the ones obtained using rt-PA. All
the ￿brinolytic agents used were able to reduce the clot size considerably when delivered together
with ultrasound.
Moreover, injection of MBs in combination with ultrasound and rt-PA may further improve the
clot lysis and increase the thrombolytic therapy [26]. However, research about this combination is
still on going and the MBs potentiality in improving clot lysis is still under study.
Furthermore, ultrasound, either alone or in conjunction with ￿brinolytic agents and MBs, is a
very attractive approach in treatment of thrombosis because of its ease of use, low costs and bedside
applicability [30].
1.3.1 Mechanisms of action and MBs in￿uence
The mechanisms of action of ultrasound in the lysis of thrombi are still poorly understood and
more studies are needed in order to understand the interaction between the ultrasound waves and
thrombi. Some possible mechanisms of action of ultrasound waves are cavitation, vibration of solid
structure, acoustic streaming and heating. However, the latter is too mild to be considered as a
possible cause of the thrombolytic e￿ect [30].
The most studied mechanism is cavitation that is the formation of bubbles within ultrasound
￿eld that undergo oscillation and disruption. More in detail, when a ￿uid is exposed to an acoustic
pressure ￿eld, gas- and vapor-￿lled bubbles are produced. This mechanism, when occurs within a
thrombus, generates fragments of ￿brin [31] characterized by irregularity and porosity [32].
There are two types of cavitation: stable cavitation and inertial cavitation. Stable cavitation
originates from bubbles oscillating with a non-linear behavior and leading to the emission at fre-
quencies that are multiple or submultiple of the central frequency. Stable cavitation is the main
cause of microstreaming production, which is the formation of small streams within the ￿uid. The
microstreaming patterns depend on the particular oscillation mode of the bubble. Microstreaming
generates shear stress in the vicinity of a bubble and this may cause the reduction of the thrombi
when the bubbles are in contact with their surface [33].
On the other side, inertial cavitation is generated by bubbles that collapse emitting broadband
noise producing microjetting [26]. Microjetting causes the pitting on solid-surfaces, and, in the
presence of thrombi, the erosion of their outmost part. Cavitation is strictly correlated with clot
mass loss and this mass loss was seen mainly in the presence of stable cavitation than in the presence
of inertial cavitation or both stable and inertial, as stated in [32]. In this article a distinction1.3. SONOTHROMBOLYSIS 13
between stable cavitation inside and at the surface of the clot is presented. Inside the clot, the
bubbles undergoing oscillation close to the ￿brin mesh expose new binding sites for plasmin that
were previously not exposed. At the surface instead, bubbles are comparable to micropumps which
make the removal of ￿brin debris easier. Further studies are necessary in order to better understand
which of the two types of cavitation mechanisms plays the major role in thrombolysis.
The ability of ultrasound to induce cavitation is described through the Mechanical Index (MI),
which is de￿ned as follows:
MI =
Pn p
f
(1.7)
Where Pn is the peak negative pressure (MPa) and f is the ultrasound transmission frequency
(MHz). The MI is displayed and can be changed in all ultrasound devices. The upper limit imposed
by the FDA is 1.9 and higher values are considered dangerous [19].
Cavitation is triggered above a certain threshold and di￿erent studies have found di￿erent cavi-
tation threshold values. For example, inertial cavitation in human blood was found to be 2.95MPa
at 2.5Mhz and 6.2MPa at 4.3Mhz [34]. Therefore, cavitation thresholds depend on frequency of the
pulse. Moreover, it was shown that continuous wave ultrasound led to lower cavitation thresholds
in the presence of rt-PA within the clot and the same trends were present for pulsed ultrasound
exposure [32]. The presence of contrast agents also lowered the cavitation threshold, thus less ultra-
sound energy was needed (one-third) in order to produce the same cavitation e￿ect as when MBs
were not used.
The cavitation properties of MBs depend on their size, concentration and shell elasticity. It is
not easy to adjust MB’s properties in order to enhance thrombolysis because most of the studies
are performed using the commercially available MBs. Therefore, it is very common to adjust the
ultrasound parameters according to the MBs used. Although the properties of the MBs are already
de￿ned, it is important to understand how these characteristics may a￿ect the sonothromboly-
sis. In [35], the in￿uence of shell elasticity and MB’s size on the e￿cacy of sonothrombolysis was
studied. The results showed that increasing the Young’s modulus increases the sonothrombolysis.
However, too high values of the Young’s modulus led to more sti￿ MBs shell, increasing the reso-
nance frequency. Concerning the size, it was shown that smaller MBs lead to the need of higher
concentrations in order to achieve optimal clot lysis. For example, it was shown that the optimal
concentration with 1mm MBs was 5.4x108 MB/mL, ￿vefold greater than the optimal concentration
of 1.1x108 MB/mL for 3mm MBs [35].
1.3.2 Ultrasound thrombolysis techniques
Since the ￿rst application of ultrasound as thrombolytic technique several studies have been per-
formed and di￿erent ultrasonic approaches have been considered. It is possible to distinguish three
main techniques:
￿ Catheter based ultrasound delivery
￿ Pulsed High Intensity Focused Ultrasound (HIFU)
￿ Surface/transcutaneous ultrasound delivery
All these approaches were studied in vitro and in vivo, both in animal studies and in human clinical
trials, with or without the use of pharmacological agents and/or MBs. In the following section a
brief description of each of these techniques and the relative studies results will be presented.14 CHAPTER 1. BACKGROUND
1.3.2.1 Catheter-delivered ultrasound thrombolysis
There are two subtypes of catheter based ultrasound delivery for thrombolysis: the catheter-
delivered transducer-tipped ultrasound and the catheter-delivered external transducer ultrasound.
The ￿rst one involves the transducer positioned directly on the tip of the catheter in order
to treat the thrombus with direct contact, without involving the surrounding tissue. Catheter-
delivered transducer-tipped ultrasound system is in clinical use for the treatment of deep venous
thrombosis and acute stroke [16] with frequencies ranging from 100kHz to 1.5MHz and intensities
up to 2W/cm2 [36]. The advantage of this method is in the reduced risk of tissue damage around
the target. This technique was also combined with plasminogen activators (rt-PA or urokinase) in
order to accelerate drug delivery within the clot and enhance thrombolysis, as shown by Tachibana
in several studies [37, 38]. Moreover, this technique was analyzed successfully with the combination
of both ￿brinolytic and contrast agents. The presence of contrast agent increased the rate of
thrombolysis by 33-51% [29].
In the second type of catheter-delivered ultrasound the transducers is positioned outside of the
body and a metal wire transmits the ultrasound signal to the tip of the catheter inserted in the body.
The length of the wire a￿ects the time necessary for clot disruption. This technique was shown to
be e￿ective in the clot dissolution of acute myocardial infarction. With this method, the frequency
used is low, in the range from 19kHz to 45kHz, whereas the intensities are much higher if compared
to the transducer-tipped method, having values up to 24W/cm 2 [36].The catheter-delivered external
transducer method produce local cavitation, microstreaming and other mechanical e￿ects, but it
does not enhance drug delivery and for this reason this technique was not applied in conjunction
with ￿brinolytic agents.
Both the types of catheter-delivered methods have the disadvantage of the invasive delivery of
ultrasound, with the possibility of the wire and catheter ￿exion, torsion and the risk of perforation
of the tissue.
1.3.2.2 Transcutaneous-delivered HIFU external ultrasound
High Intensity Focused Ultrasound is a technique that, compared to the previous one, is not invasive
and applies the ultrasound externally through a focused transducer, generally characterized by a
spherically and curved shape.
The potential of HIFU as a therapeutic method was ￿rst studied by Lynn et al in [39] and its
applicability in thrombus destruction was analyzed in [40], where a 500kHz pulsed ultrasound was
applied through a transducer with 3 piezo-electric elements and a spherical ring shape. Moreover,
the transducer had an acoustic lens with a focus point set at 45mm. The pulsed wave parameters
was found to be very important and critical for the success of the treatment. In this study no
pharmacological agents were used and no damage to the surrounding tissue was detected. Only
applying higher intensities (45W/cm2) for longer times (>5 min) led to the damage of the tissue.
More recently, in another study [41] the potential of HIFU was combined with t-PA, resulting in the
enhancement of thrombolysis. The therapeutic transducer used in this study was a custom-built
concave and spherical element with a diameter of 5cm.
In both [40] and [41] pulsed-wave has been found more e￿ective than continuous wave and it was
shown that the parameters of ultrasound signals a￿ect the results. In particular, pulse length and
duty cycle play the major role for the achievement of thrombolysis e￿ciency. Shorter duty-cycle
can reduce tissue damage, whereas longer duty-cycle leads to increased thrombolysis.1.3. SONOTHROMBOLYSIS 15
Despite the di￿erent studies that have been performed, more work is needed in order to under-
stand the feasibility and safety of this technique.
1.3.2.3 Surface ultrasound delivery
Another non-invasive approach for the delivery of ultrasounds in order to achieve lysis of the clots
consists in the use of diagnostic transducer (phased or curvilinear array), which, compared to the
HIFU technique, leads to less possibilities of tissue damage through heating.
In [42] it was shown that diagnostic ultrasound, combined with rt-PA, can enhance enzymatic
thrombolysis, reducing the recanalization time of vessels up to a depth of 50mm. The mean fre-
quency applied in this study was 1.8MHz. In several other studies, surface ultrasound delivery was
combined with MBs in order to enhance the thrombolytic e￿ciency. In [43] a diagnostic ultrasound
system with 4C1 transducer (ACUSON Sequoia 512, Siemens Medical Solutions, California) was
used in combination with MRX-801 MBs in order to assess if it was possible to achieve thrombus
dissolution with high MI (1.9) impulses. The results, during a continuous infusion of MBs, lead to
a 71% of success at 30 min of treatment in a canine model. In another study [44], high mechanical
index impulses from a diagnostic transducer combined with platelet-targeted intravenous MBs have
shown improvement in recanalization of epicardial and microvascular areas in pigs. The transducer
used was the 4V1c (Siemens Ultrasound Solution), operating at 1.5MHz with high MI (1.9). Re-
garding recent studies, it is important to mention the in-vivo investigation described in [45]. In
this study, the safety, feasibility and therapeutic e￿ectiveness of the MB enhanced thrombolysis
was analyzed using high MI (1.1-1.7) US (iE33, S5-1 transducer, Philips) applied intermittently on
pigs. In this study it was shown that inertial cavitation was the predominant mechanism in the
clot lysis, enhanced with the use of a contrast agent similar to the commercially available De￿nity.
Moreover, high MI (>1.0) was found to further increase the reduction of chronic venous thrombi in
vivo.
1.3.3 Safety and e￿ciency aspects of Sonothrombolysis
E￿ciency and safety of sonothrombolysis were deeply analyzed and studies are still ongoing. It is
not easy to assess when to consider the use of ultrasound in combination with tPA or contrast agents
completely riskless. Moreover, there is no accordance over the optimal ultrasound parameters in
order to perform e￿cient and safe treatments. A great limitation for achieving this is the small
number of patients in the di￿erent safety studies and the heterogeneities in the study protocols.
However, some important results were obtained when analyzing the ultrasound exposure in patients
with di￿erent types of thrombosis as it can be seen in the following paragraphs.
Cardiovascular thrombosis
Cardiovascular applications of sonothrombolysis resulted in higher success rate of complete lysis
and reduced time needed for coronary artery ￿ow restoration than administration of thrombolytic
agents alone. However, intensity exposure higher than 45W/cm 2, for long periods (> 5 min), led
to arterial wall damage [46]. Moreover, ultrasound approaches such as catheter-based have invasive
nature and still the design of these catheters is the major challenge due to di￿culties in transmitting
the ultrasound wave unchanged along the wire. Other approaches, such as HIFU, with the use of
low frequencies, demonstrated the ability of ultrasound deep penetration, minimal tissue attenu-
ation and mild temperature elevations. These elements are particularly important when treating16 CHAPTER 1. BACKGROUND
areas in the body which are di￿cult to reach, such as the hearth, where it is necessary to focus the
beam transthoracically considering the high attenuation of the ribs [46]. Concerning contrast agent
application, the combination of transcutaneous ultrasound with MBs in di￿erent studies demon-
strated no evidence of skin damage, lung parenchyma or coronary vasculature. Moreover, after
sonothrombolysis, the clot debris was less than 10 mm in size.
Ischemic Stroke
Considering ischemic stroke treated with ultrasound, the safety was analyzed controlling the pres-
ence of hemorrhage. In [47], it was found that sonothrombolysis in combination with intravenous
thrombolytic agent led to higher likelihood of intracerebral hemorrhage than sonothrombolysis
alone. In addition, low frequency and high intensity ultrasound has to be preferred in the treat-
ment of ischemic strokes, as stated in [48]. Another parameter considered for the safety and e￿cacy
of sonothrombolysis was the possibility of re-occlusion in the ￿rst hours after the treatment. Using
diagnostic 2MHz ultrasound probes ensures that this event will not occur.
On the opposite, other studies found that high frequency ultrasound waves were safer than
low frequency waves. Indeed, in [49] high frequency appeared to be safe with small occurrence
of intracerebral hemorrhage and with greater likelihood of complete recanalization at 3 months.
In that study, the author hypothesized that low frequency ultrasound was able to damage small
vessels, generating vasodilatation and opening of the blood-brain barrier, which is the separation
(made of conjunctions around capillaries) between blood circulation and extracellular ￿uids in the
central nervous system.
Another important result about safety of sonothrombolysis was achieved in [50], where the
clinical tests were performed using per￿utren-lipid MBs. This study demonstrated no increased
risk of symptomatic intracranial hemorrhage (presence of intracranial blood diagnosed by repeated
computed tomography or magnetic resonance imaging scanning) in patients treated with intravenous
tPA with MBs and 2MHz ultrasound.
Deep venous thrombosis
Thrombolysis using ultrasound was also found to be e￿ective and safe in the treatment of deep ve-
nous thrombosis, reducing the total infusion time of ￿brinolytic agents and lowering the likelihood
of bad outcomes such as bleeding. The reduction of the infusion time of ￿brinolytic agents is im-
portant because long infusions lead to major bleeding complication. Catheter-based ultrasound can
achieve venous recanalization, preservation of valvular function, prevention of pulmonary embolism
and improvement of quality of life [51].
Pulmonary embolism
In the treatment of pulmonary embolism, the safety of sonothrombolysis was studied employing
high-frequency, low-power ultrasound delivered through catheter-based technique in conjunction
with ￿brinolytic agent (rt-PA) [52]. The results showed complete resolution of the clot burden after
20 hours. As in the treatment of deep venous thrombosis, ultrasound can reduce the dose of lytic
agents necessary in the treatment of pulmonary embolism. This aspect is very important when
considering patients with high risks of bleeding risk complications.Chapter 2
Design, validation and optimization
of the in-vitro set-up
As stated in the introduction, the ￿rst goal of the present work was to develop an in-vitro set-up
for sonothrombosis and to evaluate its perfomance.
In this chapter the methods and results for the design and validation of the set-up are presented.
Optimization was required because some problems arose when testing the set-up. The results
obtained led to the de￿nition of a ￿nal set-up which, afterwards, was used for the evaluation of the
thrombolytic e￿ect using ultrasound in conjunction with MBs.
The design of the set-up included decision about the materials for reproducing the vessel mim-
icking phantom, mechanism of ￿ow delivery, methods for detecting sonothrombolysis e￿ciency and
methods for clot production.
2.1 Methods
The starting point for the set-up realization was the information found in [9] where the authors
modeled the microembolization in order to assess the role of sonothrombolysis in treating the no-
re￿ow phenomena, which was described in section 1.1.1.1. They used a 40 mm pore mesh (cell
strainer; Falcon Franklin Lakes, NJ, USA) mounted across the lumen of an arti￿cial blood vessel
made of rubber and with a diameter of 4mm (Figure 2.1). In this experiment the mesh was
occluded with multiple microemboli and the ultrasound treatment was delivered using a single-
element transducer at 1MHz in conjunction with per￿uorobutane gas lipid-encapsulated MBs.
Using this set-up as a reference, a new one was developed. The obtained set-up presented
two main problems: air bubble formation within the system and leakages. In order to solve these
problems, possible solutions were evaluated and the ￿nal set-up was de￿ned form the results of
these tests and optimizations.
The overall initial set-up is presented in Figure 2.2 and the main components were a vessel mim-
icking phantom, a peristaltic pump, a pressure measuring device and a programmable ultrasound
system (the Verasonics) connected to a computer.
The vessel-mimicking material of the phantom was obtained mixing 400ml of deionized water
with 15% of poly(vinyl alcohol) (PVA) and 3% of graphite as described in [53]. The PVA ensured
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Figure 2.1: The set-up proposed in [7] consisting in a rubber ￿ow phantom containing a 40 mm pore
mesh
Figure 2.2: The initial in-vitro set-up
mechanical characteristic similar to the soft tissues and the graphite was added in order to reproduce
scattering properties of tissues and tissue-like speckle texture. The mixture of PVA, graphite and
deionized water was stirred and heated up to 90 ￿C and then poured in two moulds (made of delrin
polyacetal and polymethyl methacrylate), designed in order to obtain the shape of a rectangular
prism (Figure 2.3) with a vessel lumen of 4mm in size (the same diameter as found in [9]). This
lumen size reproduce the real size of the coronary arteries, in particular the lumen of the left anterior
descending coronary artery. When the moulds were completely ￿lled with the mixture they were
stored for 12 hours at -20￿C. After that, the phantom was kept at room temperature for another 12
hours. This freeze-thaw cycle was repeated three times in order to obtain optimal vessel-mimicking
material, with speed of sound, attenuation and backscattered characteristics similar to that of soft
tissues. It was noticed that the phantom shrank in size after the three freeze-thaw cycles, keeping,
however, the predetermined lumen diameter.
The thickness of the phantom was chosen considering the ultrasound frequencies applied (4.09MHz
and 11.25MHz) and the attenuation coe￿cient (assumed equal to the soft tissues one, approximately
0.5dBcm-1MHz-1, as found in previous tests done in the laboratories of KTH). When transmitting2.1. METHODS 19
Figure 2.3: Vessel phantom
pulses at 4.09MHz the transducer was placed 25mm from the vessel lumen while the highest fre-
quency (11.25MHz) led to the need of a smaller distance, which was equal to 10mm approximately.
In this way, the ultrasound voltage in the clot area was reduced to the same value (43% of the
transmitted voltage) for both the thicknesses. In order to reproduce the microcirculation and to
keep the clots in the same position during the delivery of the ￿ow, a 40 ￿m pore mesh (cell strainer;
Falcon Franklin Lakes, NJ, USA, the same used in [9]) was placed across the vessel lumen. For
this reason the vessel phantom was composed of two halves, which were connected after positioning
the mesh between them (Figure 2.3). This design enabled to change the mesh and to extract the
remained clot, which is important when repeated measurements are being performed.
In order to reproduce the physiological ￿ow, a saline solution was delivered together with the
MBs, using a peristaltic pump (Watson Marlow, Falmouth, United Kingdom). The peristaltic pump
was set to a ￿ow velocity of approximately 8.75mm/s, which was the lowest velocity achievable
with the available pump. The ￿ow was delivered using plastic tubes 5mm in diameter and plastic
connectors were used as linkage between the tubes and the vessel phantom. After passing through
the vessel, the ￿ow solution was collected in a second reservoir.
In order to keep the two halves of the phantom together, a system with a metallic rod was
used with two movable and ￿at elements mounted on it. The two elements were regulated in order
to keep the phantom in a stable vertical position. The set-up included also an ultra-miniature
optical pressure transducer connected to the Samba 201/202 control unit (Life Science, Gothenburg,
Sweden) in order to continuously measure the upstream pressure. The pressure sensor was kept
4.5cm above the mesh for all the experiments and the data were collected using the Samba software
installed on a portable computer. The sample frequency of the Samba unit was 10Hz and the
measured pressure was the relative pressure, which was computed after calibration of the sensor
against ambient pressure. This calibration procedure was performed before each test.
The clots were produced using venous blood drawn from a healthy volunteer and stored in 4.5ml
tubes (BD Vacutainer, US) containing 0.5ml of citrate solution (0.105M), which prevents the blood20CHAPTER 2. DESIGN, VALIDATION AND OPTIMIZATION OF THE IN-VITRO SET-UP
from coagulating. In order to produce clots, 750 ￿l of blood were mixed with 60￿l of CaCl2 solution
(0,756M) in plastic Eppendorf tubes [54]. The CaCl 2 solution was prepared mixing deionized water
with granular anhydrous CaCl 2 (Sigma-Aldrich, St. Louis, MO, US) using a magnetic stirrer. The
tubes containing the mixture of blood and CaCl 2 were than incubated at room temperature for
3 hours. The obtained clots were than cut in order to obtain a size comparable to the lumen
diameter of the vessel (3-4mm approximately). As a complement to the pressure measurements,
the clot mass loss (%) was computed after each experiment. The obtained clots before each test
were bottled on an absorbent paper and weighed on a 0.001g precision scale (Sartorius, Goettingen,
Germany). After each test the clots were extracted from the vessel (taking apart the two halves
of the phantom), bottled and weighed again [55]. The clot mass loss (%) was expressed as the
di￿erence between the initial and ￿nal weight divided by the mass before the test.
The obtained in-vitro set-up was tested before the application of ultrasound, in order to assess its
functionality. Two main problems arose after the realization of the entire set-up:
1. Air bubble formation within the ￿ow immediately after clot insertion
2. Leakages of the saline solution from the vessel phantom
The air bubbles problem
The ￿rst problem was related to the fact that the insertion of the clots required to stop the ￿ow,
disconnect the uppermost tube delivering ￿ow to the phantom and extract the connector from
the arti￿cial vessel. When the connector was extracted and tube disconnected, air entered in the
system and air bubbles were formed. In order to assess the e￿ect of the air bubbles, three tests
were performed following the normal procedure during clot insertion:
￿ Disconnect the uppermost tube and extract the connector from the phantom
￿ Mimic the insertion of a clot
￿ Reposition the connector
￿ Perform the calibration against ambient pressure of the Samba sensor
￿ Connect the tube with the pressure sensor to the connector
￿ Start the 3rpm (8,75mm/s) ￿ow and the pressure measurements
In the three tests, pressure measurements were performed only for 5min because after that time no
variation in the pressure pattern was seen. This procedure enabled to see the consequences of air
bubble formation from the pressure plots within the ￿ow. These pressure measurements served as
baseline data, to which the pressure data obtained during tests of possible solutions, were compared.
In order to eliminate air bubbles from the ￿ow, two solutions were evaluated:
1. A ￿ush was performed before starting the delivery of ￿ow with the peristaltic pump
2. An infusion syringe pump delivering continuous ￿ow was used instead of the peristaltic pump2.1. METHODS 21
The ￿rst solution was to use a ￿ush to remove air bubbles. The ￿ush was delivered by setting
the peristaltic pump to run at a velocity equal to 30rpm for a time su￿cient to remove the air
bubbles within the ￿ow. As before, three pressure measurements were performed for 5min after
￿ush delivery.
The second solution for reducing air bubbles formation was to substitute the peristaltic pump
with a syringe pump (Alaris, CareFusion, San Diego, California). Therefore, the set-up was changed
in order to have continuous ￿ow. The pump used was an infusion syringe pump and the ￿ow velocity
was set to 1.5ml/min. The syringe (50ml capacity) was connected to the plastic tube that delivered
the ￿ow to the phantom. The connector between the syringe and the pump had a stopcock (BD
Medical, NJ, US) with an aperture allowing the possibility to connect a second syringe. Using the
stopcock, it was possible to choose to deliver the ￿ow from one of the two syringes. Therefore,
one syringe (50ml capacity) was used for the delivery of saline solution and MBs, while the second
syringe (20ml) allowed the injection of the clots. Also for the set-up with the syringe pump three
pressure measurements were performed for 5 min after mimicking the injection of a clot with the
20ml syringe.
For each of the situations (normal condition, ￿ush delivery and continuous infusion) the three
pressure curves were ￿ltered showing the pattern more clearly. The ￿ltering was performed av-
eraging 200 data samples around the output point using the MatLab function ￿lter. The ￿ltered
pressure measurements were normalized to the ￿rst value and the mean normalized pressure over
time for each situation was plotted together with the standard deviations bars.
The leakages problem
When the vessel of the PVA phantom was obstructed with a 3-4mm clot and the ￿ow was delivered,
the saline solution with and without MBs started to leak in the area where the two halves of the
phantom were connected. This leakage was present also when compressing the two halves with
a higher force. The leakage was probably due to the low sti￿ness of the phantom and the high
pressure generated within the ￿ow when the clot was present. In particular, when the pressure rose
due to the clot obstruction, a higher force was applied on the vessel walls, which bent leading to a
change in the overall shape of the phantom and allowing the leakage of the solution.
In order to have a sti￿er phantom a di￿erent material was tested. The material was Elastosil
M4601 silicone rubber (Wacker, Germany), obtained mixing two liquid components (90% component
A and 10% component B). Moreover, an additional silicone ￿uid (AK 35, Wacker, Germany) was
added (20% of the total) in order to obtain a lower sti￿ness. The mixture was poured in the same
moulds used for the PVA phantom and left overnight to allow solidi￿cation of the mixture. The
silicone phantom and the PVA phantom were than tested in the previously described set-up. Three
tests were performed per each of the two types of phantoms. Firstly, clots 4mm in size were bottled
and weighed. Secondly, the clots were inserted in the vessel disconnecting the uppermost connector.
Before reconnecting the tube the calibration of the pressure sensor against ambient pressure was
performed. Afterwards, the tube with the pressure sensor was connected to the phantom and an
initial ￿ush was performed. After that, saline solution was delivered at 8.75mm/s for 20min and
the pressure measurements were recorded.
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rubber attenuation coe￿cient. For this estimation, a ￿at sample (thickness 10mm) of the silicone
rubber was positioned in deionized water on a metal re￿ector. A single element transducer (deliv-
ering ultrasound at frequency of 2.25MHz) was positioned opposite to the re￿ector and perpendic-
ularly to the sample. The ultrasound was delivered using an ultrasonic pulser-receiver (Olympus,
NJ, US).
The frequency spectrum was recorded using an oscilloscope (Tektronix, Beaverton, US). The
frequency spectrum was computed ￿rstly with only the metal re￿ector without the sample and,
secondly, with the metal re￿ector and the sample. The two spectra were than used for computing
the attenuation coe￿cient knowing the distance of the transducer form the sample (10cm) and the
ultrasound velocity in water (1500m/s).2.2. RESULTS 23
2.2 Results
The air bubbles problem
Figure 2.4 presents the mean normalized pressure pattern for the normal condition as for the two
presented solutions (￿ush delivery and infusion pump application). The high standard deviation
in pressure for the normal condition veri￿es the instability caused by the presence of air bubbles
and their travelling within the ￿ow. When using the ￿ush and the continuous infusion the mean
normalized pressure had approximately a constant value during the time considered. Small standard
deviation bars veri￿es the more stable situation.
The application of the continuous infusion pump led to a set-up more similar to the physiological
situation, where no ￿ushes are present and the velocity of the ￿ow is much lower than the velocity
considered using the peristaltic pump. Moreover, qualitative observations enabled to notice reduced
leakages using the continuous infusion pump.
Figure 2.4: Mean normalized pressure pattern for the three situations: normal condition (upper)
using the peristaltic pump, after delivery of the ￿ush (mid) with the peristaltic pump and continuous
infusion (lower) with the syringe pump.
The leakages problem
The phantom made of silicone rubber, when connected to the peristaltic pump after clot insertion,
led to reduced leakages, however not eliminating completely the problem. The silicone rubber
material was sti￿er compared to the phantom made with PVA and graphite, thus the vessel walls24CHAPTER 2. DESIGN, VALIDATION AND OPTIMIZATION OF THE IN-VITRO SET-UP
bent less. In Table 2.1 the initial clot mass are reported for both the types of phantom and for each
test together with the mean pressure computed during ￿ow delivery.
Table 2.1: Initial clot mass and mean pressure value for each test during the ￿ow delivery
SILICON
PHANTOM
INITIAL
MASS
(g)
MEAN
PRESSURE
VALUE – SD
(mm Hg)
PVA
PHANTOM
INITIAL
MASS
(g)
MEAN
PRESSURE
VALUE – SD
(mm Hg)
TEST 1 0.022 44.56 – 3.91 TEST 1 0.029 -7.85 – 0.48
TEST 2 0.020 70.91 – 1.15 TEST 2 0.020 -11.22 – 0.96
TEST 3 0.020 24.28 – 2.33 TEST 3 0.025 -9.29 – 0.52
The higher values of the mean pressure considering the silicon rubber phantom verify the reduced
leakage. However, even if the general mean value of the pressure in the tests with silicone rubber
phantom was higher than in the test with PVA phantom, di￿erent pressure mean values for the
same phantom and similar clots weight were found. For example, in TEST 2 and TEST 3, using
the rubber phantom, the initial clot weight was equal (0.02g). However, the mean pressure value
obtained for the TEST 3 and computed after the ￿ush was lower than the mean value obtained
from the TEST 2. This was due to the leakage still present with the silicone rubber phantom during
￿ow delivery.
Beside considerations of the ability of silicone rubber in reducing leakages, the acoustic atten-
uation coe￿cient was also computed. The graph of the attenuation coe￿cient values expressed
in dB/cm to the respect of the frequency (MHz) is shown in Figure 2.5. Since the single element
transducer used was delivering ultrasound at 2.5MHz, the obtained attenuation coe￿cient was
computed considering this frequency. Therefore, at 2.5MHz the attenuation coe￿cient value was
8.05dB/cm. Assuming a linear dependence between the attenuation coe￿cient and the frequency,
the ￿nal attenuation coe￿cient obtained was 3.2dBcm -1MHz-1, which was higher compared to the
attenuation coe￿cient of soft tissue (approximately 0.5dBcm -1MHz-1). Switching to a sti￿er phan-
tom could reduce the leakage, but the acoustic properties of the silicon material highly reduced the
ultrasound intensity in the clot region. With a 3dBcm -1MHz-1 attenuation coe￿cient, considering
the silicon rubber material, the surrounding tissue thickness required for having low attenuation
was too small. The good compromise between sti￿ness and acoustic properties was not found.
Therefore, the silicon rubber material was not considered in the ￿nal set-up.2.3. THE FINAL IN-VITRO SET-UP 25
Figure 2.5: Acoustic attenuation of the silicon rubber material excited with ultrasound at 2.5MHz.
2.3 The ￿nal in-vitro set-up
Considering the results obtained during the optimization and validation of the initial in-vitro set-
up a new ￿nal set-up was de￿ned as shown in Figure 2.6. The silicone rubber material, even
though was able to reduce the leakage problem, had a too high attenuation coe￿cient in order to
be used during the ultrasound application. In order to have the same decrease in the transmission
voltage as for PVA phantom (43% in the mesh region), the thickness required for the silicon vessel
phantom was too small, leading to an unstable phantom. Therefore, the phantom made of PVA,
graphite and deionized water was used in the ￿nal set-up, with the wall thickness equal to 25mm or
10mm, depending on the frequency applied. The ￿nal set-up was similar to the initial one with the
exception of the pump used for the delivery of ￿ow. Instead of the peristaltic pump, the infusion
pump mentioned earlier was used. The new pump, delivering ￿ow with lower velocity (2mm/s),
reduced the instability of the set-up due to the leakages phenomena, solving at the same time the
air bubble problem. Indeed, injection of clots using a syringe and a connector with a stopcock
stopped the air form entering in the system. Moreover, since the plastic of the tube was slightly
translucent, it was possible to see the clots when injected and to stop compressing the syringe when
they entered in the phantom vessel. Therefore, delivering the clots in this way did not require
disconnecting the uppermost connector of the phantom, thus avoiding the formation of air bubbles.26CHAPTER 2. DESIGN, VALIDATION AND OPTIMIZATION OF THE IN-VITRO SET-UP
Figure 2.6: The ￿nal in-vitro set-upChapter 3
Clot lysis tests with ultrasound and
MBs
The set-up obtained after the optimization process (Figure 2.6) was used for the tests of clot lysis
with ultrasound application in conjunction with MBs. Two types of MBs, the 3MiCRON MBs and
SonoVue MBs, were considered.
The ultrasound sequences were programmed using the Verasonics architecture (Verasonics, Inc,
Redmond, WA, USA) and delivered through the L12-5 50mm and L7-4 transducers (ATL/Philips,
Bothell, WA, USA).
3.1 Methods
The two types of MBs were diluted in saline (NaCl) in order to have a concentration of 2x10 6MBs/ml
as stated in [9]. Afterwards, MBs and NaCl solution were delivered to the vessel phantom using the
50ml syringe and the infusion pump. When the MBs were seen in the clot area (applying B-mode
imaging), the sequence of long pulses was started and after 20min the clot mass loss was computed.
The upstream pressure was continuously recorded for 20 minutes. The pressure measurements and
clot mass loss were compared in order to give an estimation of the thrombolytic e￿ciency. The
time for the tests was chosen in accordance to [9, 27] where it was seen that this time was su￿cient
for the detection of the thrombolytic e￿ciency.
During the tests, the ultrasound transducer was ￿xed by a metallic holder and kept in contact
with the phantom surface, which was previously covered with ultrasound gel. The transducer was
positioned longitudinally to the vessel.
In order to develop the long pulse sequences that were transmitted to the clot area, a code
was programmed using the Verasonics software. The code was written in MatLab (MathWorks,
Massachusetts, US) and completely reported in the Appendix.
In the following sections the MBs production, the implemented protocols and the Verasonics
ultrasound system architecture are described.
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3.1.1 Production of 3MiCRON MBs
The production of the novel agent was described in [25] and was performed preparing two batches
that were later added together. For each batch, 200 ml of MilliQ water were mixed with 4g PVA
(2%) and heated up to 80 ￿C. When the mixture reached the desired temperature, 380mg of NalO 4
were added and the solution was kept at 80 ￿C for 1 hour continuously agitated with a magnetic
stirrer. After 1 hour the mixture underwent high shear stirring (8000rpm for 3 hours) in order to
selectively split the head-to-head sequence contained in the PVA chains. This stirring was achieved
using an Ultra Turrax (IKA, Germany) at room temperature. The resulting batch was washed seven
times every 24 hours. The obtained MBs have a mean diameter of 3 ￿m and they can be stored
in water for months due to their high stability. Before their application, MBs concentration was
assessed using a light microscope and a counting chamber as described in the protocol presented by
Pretzl and Cerroni in [56]. Brie￿y, MBs solution was diluted (1:5) and transferred into the Neubauer
counting chamber that has squares with an area of 0.25x0.25mm and a depth of 0.1mm. The images
(Figure 3.1) were taken with a transmission microscope (20x objective) and transformed in binary
pictures using ImageJ Analysis Software. The binary pictures were than used by the software
in order to count the particles. Four squares were imaged and analyzed and the mean number
of particles was used for the computation of the concentration. The obtained concentration was
109MBs/ml.
Figure 3.1: Image of 3MiCRON MBs with transmission microscope (objective 20x)
3.1.2 Production of SonoVue MBs
The protocol for the SonoVue MBs preparation was ￿xed by the manufacturer that delivers the
SonoVue contrast agent as a kit with a vial containing a lyophilized powder (25mg) and a syringe
pre￿lled with sterile saline solution (5ml). To prepare the MBs the saline solution and the powder
were mixed for 20s. The obtained suspension can be stored for 6 hours and if the MBs accumulate
at the upper surface the suspension should be shacked again before the application. The obtained
MBs have a concentration of 1-5x10 8MBs/ml.3.1. METHODS 29
3.1.3 Implemented protocols for ultrasound transmission
In order to apply ultrasound with a frequency close to the resonance frequency of the two types of
MBs (1-4MHz for SonoVue and 12MHz for 3MiCRON), the L12-5 50mm transducer transmitting
at a frequency equal to 11.25MHz (highest value achievable) and the L7-4 transducer transmitting
at 4.09MHz (lowest value achievable) were used. Four protocols for ultrasound transmission were
developed and tested. For each of the protocols seven tests were performed. MBs were delivered
after clot injection and, when they were seen in the clot region, ultrasound exposure was performed
for 20 minutes. Moreover, seven control tests with no ultrasound and no MBs were executed and
used as reference. In Table 3.1 the di￿erent protocols are summarized.
Table 3.1: The protocols developed and tested
MBs
TYPES
TRANSDUCER/
FREQUENCY
(MHz)
VOLTAGE
(V)
PULSE
DURATION
(ms)
DISTANCE
TRANSDUC-
ER/CLOT
(mm)
NUMBER
TRANSMIT-
TING
ELEMENTS
3MiCRON L12-5 50mm/11.25 100 5 10 56
3MiCRON L7-4/4.09 100 5 25 40
SonoVue L7-4/4.09 100 5 25 40
SonoVue L7-4/4.09 50 10 25 40
The ultrasound focus was set within the clot region and the long pulses were sent from a subset
of transducers elements in order to cover an area of 10-11mm that included the clot and a small
surrounding region.
The distance between the transducer and the clot area was approximately 10mm in the ￿rst
protocol, where the L12-5 50mm transducer was used. In the remaining protocols, since the fre-
quency applied was lower, the distance was set equal to 25mm. The highest voltage applied during
the long pulse delivery was equal to 100V, the highest value achievable, due to safety aspects of the
system.
Between the long pulses, idle time was set in order to enable the MBs replenishment. Indeed,
with a ￿ow velocity equal to 2mm/s, the time necessary for the MBs replenishment was approxi-
mately 6s.
During the exposure of the clots to ultrasound and MBs, no imaging was performed except at
one time point to check the e￿ective MBs replenishment. This imaging was performed during the
idle time between two trains of pulses using the already built-in MatLab script provided with the
Verasonic software and opportunely modi￿ed for having imaging only during the idle time and not
during the transmission of the long pulses. In this way, in the case of MBs destruction within the
clot region during the long pulse delivery, imaging enabled to see if the idle time was su￿cient for
letting new MBs to reach the area.
For each group of tests the clot mass loss was computed and the mean initial mass and mean
mass reduction with the respective standard deviation was calculated. Statistical analysis was
performed applying the student’s t-test in order to compare the mass loss for each protocol with
the control group. Statistical signi￿cance was de￿ned as p<0.05.
Beside clot mass loss, three pressure measurements for three di￿erent tests within each protocol
were considered. The pressure plots were only three due to the di￿cult reproducibility of the
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The pressure measurements of the three considered tests were ￿ltered using an average ￿lter.
The ￿ltering was performed averaging 200 data around the output value using the MatLab function
￿lter. Afterwards, pressure plots were normalized to the ￿rst value and the mean normalized pressure
was plotted together with standard deviations bars. Normalization of the plots was necessary in
order to allow comparisons due to the fact that slightly di￿erent values in the initial clot mass led
to di￿erent initial pressure values.
Each long pulse delivered using the Verasonics system consisted in trains of pulses and in Table
3.2 their characteristics are summarized for all the protocols. In the next sections the explanation
of each pulse sequence will be provided.
Table 3.2: Train of pulses characteristics.
PROTOCOL SINGLE PULSE
DURATION
(ms)
IDLE TIME
(ms)
NUMBER
OF PULSES
3MiCRON and
high frequency
88.18 35.82 40
3MiCRON and low
frequency
240 7 20
SonoVue and low
frequency
240 7 20
SonoVue with
longer pulse and
lower voltage
240 7 40
3.1.3.1 Control tests: no MBs and no ultrasound application
Control tests were performed delivering saline solution without MBs after clots injection. Ultra-
sound was used just for imaging purposes and the long pulses with high voltage were not applied.
In order to image the clot area, the L7-4 transducer was used and B-mode images were obtained
using the already built-in MatLab script provided with the Verasonic software.
3.1.3.2 3MiCRON and high frequency exposure
In this protocol, the 3MiCRON MBs and long ultrasound pulses (5ms), with a frequency equal to
11.25MHz and voltage set to 100V, were applied (Table 3.1, ￿rst row).
The long pulses were sent from the 56 central elements of the L12_5 50mm transducer (Figure
3.2). Each element transmitted trains of pulses obtained combining 40 pulses, each with duration
of 88.18￿s (Table 3.2, ￿rst row), which is the maximal single pulse duration achievable with the
Verasonics architecture and with a frequency equal to 11.25MHz . The idle time between these
pulses had duration of 35.82￿s. Therefore, 40 pulses with 88.18￿s duration and 35.82￿s of idle time
led to a train of pulses with total duration of 5ms. A schematic representation of the ultrasound
pulse sequence is shown in Figure 3.3.3.1. METHODS 31
Figure 3.2: The ultrasound ￿eld using the L12-5 50mm transducer.
Figure 3.3: The ultrasound pulse sequence
3.1.3.3 3MiCRON/SonoVue and low frequency exposure
Two protocols were identical with the exception of MBs used. For both the types of MBs the
frequency applied was 4.09MHz and the long pulse had duration of 5ms (Table 3.2, second and
third row). The long pulses were sent from the 40 central elements (Figure 3.4) and they were
obtained combining 20 pulses, each with duration of 240 ￿s, which is the maximal length achievable
with the Verasonics system and with a frequency equal to 4.09MHz (Table 3.2, second and third32 CHAPTER 3. CLOT LYSIS TESTS WITH ULTRASOUND AND MBS
rows). The idle time between these pulses had duration of 7 ￿s. Therefore, combination of 20 of
these pulses led to a train of pulses with duration of 5ms (Figure 3.5).
Figure 3.4: Ultrasound ￿eld with transducer L7-4.3.1. METHODS 33
Figure 3.5: The ultrasound pulse sequence
3.1.3.4 SonoVue with longer pulse and lower voltage exposure
In this protocol SonoVue MBs were considered with ultrasound exposure at a frequency of 4.09MHz.
The voltage was reduced by 50% and long pulse duration was doubled in comparison to the previous
protocols (Table 3.2, last row).
The long pulses were sent from the 40 central elements and in order to achieve 10ms duration, 40
pulses of the same duration and the same idle time as in the previous two protocols were combined
(Figure 3.6 and Table 3.2, last row).
Figure 3.6: The ultrasound pulse sequence.34 CHAPTER 3. CLOT LYSIS TESTS WITH ULTRASOUND AND MBS
3.1.4 The Verasonics system
The aim of this section is not to provide a complete description of the Verasonics architecture, but
only an overview in order to better understand the developed code. For a detailed explanation of
the Verasonic system the reader should refer to the Verasonics Sequence Programming Manual.
The Verasonics system is an ultrasound system architecture (Figure 3.7 ) that enables imple-
mentation of traditional and new ultrasound sequences. Moreover, it is very ￿exible in transmitting,
receiving and processing ultrasound. The Verasonics architecture allows also the simulation of the
system using a software simulator running on the host computer. This enables the possibility to
check the programmed sequence before running it with the probe and the hardware.
Figure 3.7: The Verasonics system (picture taken from the Verasonics brochure)
The Software-based System
The system is programmed generating a collection of objects which are de￿ned using a MatLab
script and characterized by speci￿c attributes. After executing the script, a MatLab.mat ￿le is
generated, which can be loaded into the system by the VSX program (Verasonic Script eXecution).
This program performs checks on the script and adds other attributes necessary for the Verasonics
Data Acquisition System (VDAS) hardware. At the same time a GUI and a display window are
displayed. The GUI panel allows the user to change some parameters such as voltage, gain and the
dynamic range, while the display window reproduces the image of the region where the ultrasound
waves are delivered.
In the ￿nal step the sequence is loaded into the hardware sequencer and executed.
The VDAS Hardware
The VDAS hardware is schematically shown in Figure 3.8 . The front of the available 4 board system
is composed by a scanhead interface with two connectors for plugging the desired transducers. The
128 channels of the ￿rst connector are connected to the 128 A transmitters and the 128 channels of
the second connector are connected to the 128 B transmitters. The connectors include a system for3.1. METHODS 35
detecting the presence of the probe and for allowing the execution of the sequence event without it.
The acquisition modules are stored inside the chassis and they contain the circuitry for transmitting
and receiving the signals for multiple channels. These modules contain also a local memory for the
storage of the received signals before sending them to the host computer. The VDAS hardware
contains also a Transmit Power Controller module which has the high voltage supplier for the
transmitters. This module allows for high power bursts and extended pulse length.
Figure 3.8: The VDAS hardware (picture taken from the Verasonics Tutorial)
The Objects de￿nition
The objects that have to be de￿ned in the MatLab script in order to run the sequence can be
subdivided in two groups:
1. The System objects: this group of objects is needed in order to de￿ne the transducer used,
the scanning format and the pixel data region. It also includes the resource object, which
contains information about the storage bu￿ers.
2. The Sequence objects: this set of objects include instructions for the transmission, recep-
tion, reconstruction and processing of the ultrasound. Moreover, through the Event object,
it is possible to de￿ne the events for acquiring one or more frames of data.
Each object is de￿ned and described by a set of attributes. For example, some of the Transducer
attributes are:
￿ name: a string containing the scanhead name
￿ frequency: the center frequency expressed in MHz
￿ type: linear, curvilinear or 2D
￿ elementWidth: the element width expressed in wavelength
￿ spacing: the element spacing in wavelength
￿ radius: the radius of curvature
For a complete list of the attributes for the transducer and for all the other objects, the reader
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3.1.5 The implemented codes
In order to program the Verasonics system and the transducer for the delivery of long train of pulses,
the following objects have to be de￿ned in the MatLab code: some initial resource parameters, the
transducer, the storage bu￿er, the waveform, the transmission, the time gain controller, the receiving
process, the control sequence and the list of the events.
For each of the protocols a code was implemented. The objects de￿ned in these codes are
presented in the following section. The complete code for each protocol is reported in the Appendix.
The distance units in the code are expressed in wavelengths ( l) computed considering the central
frequency of each transducer (5MHz for the L7-4 and 9MHz for the L12-5 50mm).
3.1.5.1 The Resource.Parameters attribute
The resource.Parameters stores some attributes that are global and required for the con￿guration
of the system. These parameters were set equal for all the codes. In the developed sequences the
parameters that had to be de￿ned were the number of transmit and receive channels (128 for both)
and the speed of sound (1540m/s). The simulationMode and fakeScanhead attributes, when set
to 1, allowed running the program respectively in simulation mode or without the probe. These
attributes enabled to check the pulse sequence before running the program with the hardware and
the probe.
3.1.5.2 The Transducer object
For each ultrasound probe used, a Trans object was de￿ned. Setting the Trans.name attribute
equal to ‘L12-5 50mm’ and to ‘L7-4’ and running the function computeTrans led to the de￿nition
of transducers with the characteristics presented in Table 3.3 .
Table 3.3: The transducer attributes.
TRANS ATTRIBUTE DESCRIPTION L12-5 50mm L7-4
numelements Number of
elements in the
transducer
256 128
frequency Central frequency
of the transducer
9MHz
(l1=0.17￿m)
5MHz
(l2=0.3￿m)
spacing The spacing
between the
elements, including
the element width
1.14l1 0.97l2
maxHighVoltage Maximal voltage
(half of the peak to
peak value)
50 50
impedance Complex
impedance at the
central frequency
45-60i 45-60i3.1. METHODS 37
3.1.5.3 The Resource object
If imaging is not needed, no storage bu￿ers are needed. However the VSX program requires that
at least one storage bu￿er is de￿ned. For this purpose, for all the protocols, one odd RcvBu￿er
was speci￿ed for the storage of the data from the local memories on the VDAS modules. However,
these data were not further processed. The RcvBu￿er contained a number of frames that was set
to 1 in order to let the program to run.
3.1.5.4 The TW object
The TW object de￿nes the transmit waveform for each transmitter. The type was set to ‘para-
metric’ because it had to be generated by the VDAS hardware. The parametric waveform was
described by the four descriptors in the TW.Parameters (A, B, C and D), di￿erent for the two
transducers used, and by the extendBL attribute, always set equal to 1. In Table 3.4 the values set
for the two transducers are presented.
Table 3.4: The TW attributes. A value chosen according to Table 3.2.1.1 in the Verasonics Sequence
Programming Manual.
TW ATTRIBUTE DESCRIPTION L12-5 50mm L7-4
Parameters
A waveform
frequency
expressed by the
number of transmit
clock periods in a
half cycle
8 (11.25MHz) 22 (4.09MHz)
B the duty cycle
period expressed
by the number of
transmit clock
periods the positive
or negative drive is
active during the
half cycle period
3 (37%) 8 (37%)
C the pulse length
expressed by the
numbers of half
cycle periods (0-31)
31 (1.38￿s) 31 (3.7￿s)
D the polarity: 1
(￿rst transmission
positive) or -1
(￿rst transmission
negative)
1 1
extendedBL If set to 1 lead to
the multiplication
of the C value by
64
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3.1.5.5 The TX object
This object de￿nes all the aspects about the transmit waveform and the timing for each of the
active element in the transducer aperture. The attribute that were set equally in all the codes
were the waveform, the origin and the transmitter delay. For each of the active transmitter the
used waveform was the one de￿ned in the TW object. For this reason the waveform attribute
of the TX object was set to 1. In this way, all the transmit elements were characterized by the
same waveform. The origin point, which is the point on the transducer that the beam appears to
originate from, was de￿ned setting the x, y, z coordinates equal to 0. The delay for each active
transmitter was computed calling the function computeTXDelays(TX(1)) that is already available
within the Verasonic software.
The attributes that were set di￿erently for the two transducers were the focus value, the Apod
array for the selection of the active transmitters and the transducer aperture. These values are
reported in Table 3.5.
TX ATTRIBUTE DESCRIPTION L12-5 50mm L7-4
focus Focal distance in
wavelengths
60l1 85l2
aperture Selects a
sub-aperture of the
full array aperture
65 (because
transmit
channels=128,
while
Trans.numelements
= 256)
Not needed
Apod Array with 0
(transmitter on)
and 1 (transmitter
o￿) values
56 central values
equal to 1. The
other 72 equal to 0.
40 central values
equal to 1. The
other 88 equal to 0.
Table 3.5: The TX attribute
3.1.5.6 The TPC object
The Verasonics Transmit Power Controller is an object that provides for rapid changes in high
voltage output, allowing the use of di￿erent power levels for di￿erent modes of acquisition. Each
power level can have its own set of unique attributes, including speci￿cation of transmit drive
voltage level, and maximum power output. The collection of attributes for a given power level is
referred to as a pro￿le, and up to four pro￿les are supported in the current TPC ￿rmware, with a
￿fth available as a ￿high power￿ option. The TPC pro￿le 5 allows use of the system at very high
transmit power levels. In particular, the " Extended Burst Option" utilizes a dedicated internal
power supply with 48 Watt capacity to power the HIFU transmit bursts. A large energy storage
capacitor provided within the system allows transmit for short bursts at much higher power levels,
provided that enough time is allowed between bursts to recharge the capacitor from the internal
supply. The amount of transmit power available is highly dependent on the transmit burst duration,
the number of active transmit channels, and the load impedance presented by the transducer to the
system. The pro￿le 5, when de￿ned in the code, enabled the use of the extendBL attribute, which
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For the protocols where 100V were applied, the maximal voltage was set to 50V, meaning a
peak to peak value of 100V, de￿ning the maxHighVoltage and highVoltageLimit of pro￿le 5 equal
to 50.
3.1.5.7 The TGC object
When imaging is not needed, the Time Gain Compensation is not necessary. However, the Verasonic
VDAS requires the de￿nition of at least one TGC object that has to be referenced in the Receive
object (see next paragraph). In the developed script the TGC object used was the same found in
all the scripts already provided within the Verasonic software.
3.1.5.8 The Receive object
This object de￿nes all the characteristics of the receive phase of an acquisition event. Therefore,
when imaging is not required, this object is not needed. However, as the RcvBu￿er had to be de￿ned
also the associate Receive structure had to be set in order to run the VDAS program. Therefore,
the MatLab code was taken from an already built in script just to de￿ne a simple Receive object
and let the VDAS to run.
3.1.5.9 The Sequence Control object and the Event object
The SeqControl object provides the ￿ow control of the Events which are de￿ned immediately after.
For all the codes the ￿rst Event that had to be de￿ned was the one that enabled to switch to
pro￿le 5. The associated SeqControl commands used were ‘ setTPCPro￿le’ with the argument set
to 5 and the ‘noop’ command set to 8ms. The ￿rst command enables the transmission using the
high power pro￿le 5, while the second set 8ms for ensuring enough time to change to pro￿le 5, due
to the not immediate switching.
The Events for the delivery of the long train of pulses were slightly di￿erent for the di￿erent
codes depending on the number of single pulses that were sent. For having 5ms train of pulses at
11.25MHz and 10ms at 4.09MHz, 40 events were required. on the other hand, for having 5ms train
of pulses at 4.09MHz, 20 events were required.
After the train of pulses was sent, 6s of idle time were set for MBs replenishment. After this
period of time the sequence was repeated from the second event (the one immediately after the
setting of the pro￿le 5) using the SeqControl command ‘ jump’ . When the command ‘jump’ was
called, an unconditional branch was performed to the event indicated in the argument which in the
speci￿c case was the number 2. In the end, the last events after the ‘ jump’ command were required in
order to run the VDAS program. Indeed, this program required that at least one ‘ transferToHost’
command was set, generating a command needed by the VSX. The ‘ transferToHost’ command
required that at least one receiving event was present. In order to satisfy this request a sham
receiving event using the fake Receive object and RcvBu￿er was set.40 CHAPTER 3. CLOT LYSIS TESTS WITH ULTRASOUND AND MBS
3.2 Results
Table 3.6 summarizes the initial mean weight and the mean mass loss, with the corresponding p
value, for the control tests and the four protocols. Moreover, in Figure 3.9 the change in upstream
pressure over exposure time is presented.
Table 3.6: Initial mean weight and mean mass loss for each protocol (control tests included). NS=
not signi￿cant, n=number of clots tested.
PROTOCOL INITIAL
MEAN
WEIGHT
–SD (g)
MEAN
MASS LOSS
– SD (%)
p-value
Control tests
(n=7)
0.064 – 0.007 38 – 9.6 -
3MiCRON and
high frequency
(n=7)
0.054 –0.01 37 – 9.7 NS
3MiCRON and
low frequency
(n=7)
0.063 – 0.01 37.2 – 5.4 NS
SonoVue and
low frequency
(n=7)
0.051 – 0.01 35.8 – 6.3 NS
SonoVue with
longer pulse and
lower voltage
(n=7)
0.063 – 0.01 49 – 7.9 0.0253.2. RESULTS 41
Figure 3.9: Mean normalized pressure plots for all the protocols (control tests included).
Clot mass loss was in general seen for all the protocols (control tests included). However this
was not the case for the pressure measurement where decreased values were mainly seen for the
SonoVue MBs exposed to low voltage. One possible explanation for this is that the saline ￿ow
produced clots debris which remained entrapped within the mesh, hence not allowing the ￿ow to
be restored and keeping the pressure to high values.
As it can be seen in Table 3.6, the ￿rst three protocols led to a mean mass loss comparable to the
one obtained during the control tests and no statistical di￿erence was seen between these protocols
and the control tests. In the protocols where the 3MiCRON MBs were used, it was possible to see
that there were no frequency-dependent variations in the clot mass loss. For both these protocols,
it was possible to see form the images between long pulses, that the 3MiCRON MBs were not
destroyed.
On the other side, in the protocol where SonoVue MBs were used with low frequency exposure,
MBs destruction was noticed after pulse delivery.
In the last protocol lower SonoVue MBs destruction was seen. Moreover, increased clot lysis was
noticed, as con￿rmed through the clot mass loss computation. Indeed, a 10% increase in the clot
mass loss was seen compared to the control tests. The p value con￿rmed the statistical di￿erence
between this protocol and the control tests.
The mean pressure over time for this protocol was characterized by an early decrease in the
￿rst 4 minutes, followed by a plateau region. The early decrease is in accordance with [9], where
the maximal thrombolyitic e￿ect was seen within the ￿rst 3min. Furthermore, the mean normal-
ized pressure presented a 15% decrease over the 20min of testing with standard deviations within
acceptable ranges.42 CHAPTER 3. CLOT LYSIS TESTS WITH ULTRASOUND AND MBSChapter 4
Discussion and Conclusions
4.1 Design and optimization of the in-vitro set-up
As it can be seen from the results obtained during the validation process, the optimal set-up was
not easy to achieve.
Several problems arose during the realization and the main ones were related to leakage problems
and air bubble formation.
The air bubbles formation was e￿ectively solved switching from the peristaltic pump to the
infusion pump. Air bubbles led to the presence of some random peaks in the pressure patterns.
After the ￿ush and during the continuous infusion the pressure curves were more regular and no
random peaks were present. Therefore, air bubbles formation was avoided. The solution chosen for
the ￿nal set-up was to use the continuous infusion pump because, beside eliminating the problem
of the air bubbles formation, it led to a more realistic set-up.
The leakage problems a￿ected the pressure measurements, which were not always reliable as the
clot mass computation before and after each test.
The ￿nal in-vitro set-up presented several aspects similar to the physiological situation of oc-
cluded coronary arteries. The vessel lumen was 4mm in size, comparable to the dimension of the
left anterior descending coronary artery. Moreover, the 40 ￿m pore mesh reproduced the microcir-
culation and the ￿ow velocity was 2mm/s, similar to the real situation value. Lastly, the material
of the phantom had acoustic properties comparable with the soft tissues ones.
On the other side, the distance between the clot region and the ultrasound transducer was not
comparable to the real distance between the probe and the coronary arteries. Moreover, in the
real situation the presence of the ribs and other body structures that can attenuate and scatter the
ultrasound waves makes the application of linear transducers not possible. Another limitation of
the in-vitro set-up was the continuous ￿ow delivery, which is not present in the real situation where
the ￿ow is pulsatile. Moreover, the implemented set-up did not allow estimation of the clot debris
stuck in the mesh.
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4.2 Test of the in-vitro set-up with ultrasound and MBs
In general, using the Verasonics system, several limitations in the coding and implementation of
di￿erent combinations of ultrasound parameters were found. This was due to the fact that the entire
system had power limitations and hardware constraints that did not allow realization of continuous
long pulses. Another general limitation for all the protocols (control tests included) was the low
number of tests performed. Higher number of tests will enable more reliable statistics.
4.2.1 Control tests
The control tests, with no application of ultrasound and MBs led to a mean mass loss equal to 38
– 9.6 %.
In another study [30], were ultrasound e￿ciency was studied in a set-up were no ￿ow was present,
the control test (20min of clot immersion in saline solution) led to a clot reduction of 29 – 11%.
The weighing procedure was similar to the one presented in this work. The higher clot mass loss
found in the present project was probably due to the ￿ow delivery, which may be able to further
reduce the clot size. Another aspect to consider is that the clots produced in [30] are obtained
letting human blood to coagulate spontaneously after being drawn. The di￿erent methods for clots
production may be another reason for di￿erent values in clot mass loss. Moreover, the mean initial
weight of the clots produced within this project was much lower than the mean weight of the clots
found in [30], because of the 4mm diameter vessel. Indeed, the mean initial mass of the 3-4mm
clots computed considering all the tests of all the protocols (control tests included) was 0.057 –
0.01 g. In [30] that value was equal to 0.498 – 0.073 with a size of approximately 1cm. The small
dimension of the clots used in the present project led to a more di￿cult mass loss computation.
Comparing the results obtained computing the clots mass loss and the pressure measurements
during the control tests it seemed that the pressure sensor was not able to detect the 38% mass
loss. Therefore, potential clot debris was probably bigger in size than the mesh pores (40 ￿m),
hence remaining stuck in the mesh and keeping the pressure to high values. In a real physiological
situation this will lead to the occlusion of the microcirculation (approximately 40 ￿m in size). A
further study with a microscope, in order to analyze the mesh, may con￿rm this possibility.
4.2.2 3MiCRON with high and low frequency exposure
The frequency value of 4.09MHz, applied delivering 3MiCRON MBs was lower than the resonance
frequency. On the other side, the highest frequency applied was closer to the resonance frequency,
but still not equal due to the transducer used and the Verasonics hardware limitation. The enhance-
ment of the non-linear oscillation of 3MiCRON MBs is maximal when the resonance frequency is
applied. In the tests performed the MBs might have passed the clot and the mesh without any e￿ect
when delivering ultrasound at 4.09MHz and also the highest value may has not been su￿cient. If
non-linear oscillation is considered as one possible reason for clot lysis, in the considered tests the
oscillation may has not been enhanced su￿ciently in order to increase the clot reduction.
In [30], application of ultrasound without MBs led to decreasing thrombolysis e￿ciency with
increasing frequency. Considering this result, a limitation of the 3MiCRON MBs might be the need
of very high frequencies in order to trigger an oscillation that can improve the clot lysis.
For both the protocols where 3MiCRON MBs were applied, the intensity delivered to the clot
area was reduced by 43% of the transmitted value. Therefore, of the 100V sent from the transducers,
57V reached the clot. The voltage is the only indication of the ultrasound wave amplitude. No4.2. TEST OF THE IN-VITRO SET-UP WITH ULTRASOUND AND MBS 45
information about the intensity or pressure was available due to the fact that the Verasonics system
enabled only the setting of the voltage. Thus, the mechanical index could not be computed and
the comparison with other studies mentioned in the background section was di￿cult. The images
after the long trains of pulses did not show regions were no bubbles were present and one possible
explanation of this could be that the intensity was not enough high to disrupt the MBs. 3MiCRON
MBs have much sti￿er shell than other lipid-encapsulated MBs, hence they may require very high
values of intensity, not achievable with the L7-4 and L12-5 50mm transducers and the Verasonics
system.
In [9], a peak-to-peak acoustic pressure of 1.5MPa led to high thrombolytic e￿ciency in the
￿rst 5min of testing with 5ms pulse duration. In detail, the pressure decreased by 75% over 20min
of testing. In the present work no pressure decrease was found, thus the value of 57V in the clot
region might not be su￿cient for triggering the cavitation process or MBs oscillation. Moreover, in
[34] it was seen that cavitation threshold increased with increasing frequencies values. Therefore,
if the cavitation is supposed to be one of the main mechanisms of clot lysis, in the present study
the threshold could have been greatly increased applying a frequency equal to 11.25MHz.
The ultrasound train of pulse with duration of 5ms was chosen in accordance to the value used
in [9]. However, in [9] the pulse length was delivered form a single element transducer and the 5ms
pulse was continuous. In the present work the 5ms pulse was composed by several shorter pulses
with small idle times in between. More in detail, using the L12-5 50mm transducer, the longest
pulse achievable with 11.25MHz had a duration of 88.18 ￿s, while the L7-4 transmitting at 4.09MHz
enabled pulses with maximal duration of 240￿s . Thus, in order to obtain a longer pulse, several of
these short pulses were combined. The idle time in between was the lowest achievable and smaller
values were not possible due to power limitations. Moreover, each pulse had a duty cycle equal to
37%. Low values of duty cycle led to irregular waveforms, thus the ￿nal ultrasound wave did not
have a regular sinusoidal shape with alternating phases of compression and rarefaction.
Due to several power limitation of the system, good compromise between voltage, pulse duration,
duty cycle and idle time between pulses had to be found. In order to transmit at 100V, the train
of 88.18￿s and of 240￿s pulses could not be longer than 5ms. All these limitation in pulse length
may a￿ect the ultrasound e￿ciency in clot lysis and ultrasound interaction with MBs.
4.2.3 SonoVue and low frequency exposure
For the SonoVue MBs it was seen that the pulse burst the bubbles, thus creating a dark area within
the ￿ow where almost no bubbles were present. This result is in accordance to previous knowledge,
namely that SonoVue bubbles are easier to break compared to the 3MiCORN MBs, which remained
intact when the same ultrasound pulse was delivered.
As seen in the results, this protocol led the conclusion that no improvement in clot lysis was
seen compared to the control tests. One possible explanation of this result is that the 100V pulses
were able to destroy the SonoVue bubbles without triggering any process of clot lysis. As stated in
the Background, several studies found that inertial cavitation (generated when MBs are disrupted)
was less e￿ective in clot lysis compared with stable cavitation. Stable cavitation was probably not
possible for SonoVue MBs due to their disruption. This could have led to ine￿ective clot reduction.
The frequency applied, 4.09MHz was almost in the range of the resonance frequencies for
SonoVue (1-4MHz), but the disruption of the bubbles did not allow evaluation of the e￿ects of
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4.2.4 SonoVue with longer pulse and lower voltage exposure
According to the results obtained in the previous protocol, a new pulse sequence was developed
for the ultrasound application with SonoVue MBs. The lower voltage was set in order to reduce
the bubble destruction which was still present but with lower severity. Furthermore, reducing the
voltage, it was possible to program a train of pulses with longer duration (10ms). Longer pulses
were implemented because they were seen e￿ective in clot lysis in several studies. In [9], ￿ve pulses
with increased duration (from 0.1ms to 5ms) were compared, resulting in highest thrombolyitic
e￿ciency with 5ms duration. Moreover, also in [30] it was seen that thrombolysis e￿ciency (%)
increased with pulse duration.
As seen in the results, the implemented pulse sequence, in conjunction with SonoVue MBs was
able to improve the clot lysis. This may be due to the fact that lower voltage reduced the MBs
destruction, while the longer pulse duration enabled the enhancement of MBs interaction with the
clot. The MBs that were not destroyed were triggered with a pulse which, with longer duration and
with a frequency within the range of the resonance frequency for the SonoVue, could have improved
the MBs oscillation. Furthermore, the MBs oscillation could have enhanced the cavitation within
the clot area, increasing the clot lysis.
4.3 Conclusion
In the present work, a set-up for sonothrombosis was designed and tested.
The set-up presented several aspects that enabled its comparison with the physiological situation
of coronary arteries occlusion, allowing testing of clot lysis with ultrasound exposure in conjunction
with MBs. However, the set-up had also several limitations and two main problems were found: air
bubbles formation within the ￿ow and leakages phenomena. The ￿rst one was completely solved,
while the leakage was only reduced.
The obtained set-up and the implemented ultrasound sequences were able to allow a ￿rst study
of the sonothrombolysis with 3MiCRON and SonoVue MBs. From the developed protocols it was
seen that 10ms long pulses, delivered at 50V in conjunction with SonoVue MBs, were able to
improve the clot lysis by 10% compared to the control tests and to the tests where the 3MiCRON
MBs were used.
4.4 Future work
The set-up has to be further optimized in order to eliminate the leakage problem and to obtain more
reliable pressure measurements. Di￿erent phantom materials and geometries should be considered
and tested in order to address these problems. Furthermore, the e￿ciency of the clot lysis should
be computed considering also the clot debris stuck in the 40 ￿m pore mesh. Developing a method
for analyzing the material entrapped in the mesh, it will be possible to see if the reason of not
varying pressure over 20min was due to clot debris bigger in size than the mesh pores.
The programmed ultrasound sequences have to be further modi￿ed and tested in order to
evaluate possible e￿ects in clot lysis with di￿erent combination of ultrasound parameters. Di￿erent
pulse lengths, voltages and frequencies should be tested in order to ￿nd the right combination
for higher thrombolytic e￿ects when delivering 3MiCRON or SonoVue MBs. In addition, the
application of di￿erent transducers should be considered. For example, using a single-element4.4. FUTURE WORK 47
transducer it will be possible to have fewer limitations compared with the programmable system,
although the setting will be less realistic when compared to the clinical one.48 CHAPTER 4. DISCUSSION AND CONCLUSIONSBibliography
[1] Media centre, WHO, The 10 leading causes of death by broad income group (2008), Updated
June 2011, http://who.int/mediacentre/factsheets/fs310/en/ (accessed 07/06/2013).
[2] Walter F. Boron, Emile L. Boulpaep, ￿Special circulation￿ in Medical Physiology, Updated
Edition, Philadelphia: Elsevier Saunders 2005, ch 23, 562-565
[3] Lippi G et al., ￿Arterial thrombus formation in cardiovascular disease￿, Nat. Rev Cardiol.,
2011; 8(9); 502-512
[4] Robert S. Shwartz, ￿Microemboli and microvascular obstruction in acute coronary thrombosis
and sudden coronary death￿, Journal of the American College of Cardiology, 2009; Vol 53; No
23.
[5] Aldons J. Lusis, ￿Atherosclerosis￿, Nature,2000, vol 407; 233-241.
[6] Legein et al., ￿In￿ammation and immune system interactions in atherosclerosis￿, Cell. Mol.
Life Sci., 2013, DOI 10.1007/S00018-013-1289-1.
[7] Linco￿ AM, Topol EJ, ￿Illusion of reperfusion.Does anyone achieve optimal reperfusion during
acute myocardial infarction?￿, Circulation, 1993; 88; 1361-1374
[8] Ito H., ￿No re￿ow phenomenon and prognosis in patients with acute myocardial infarction￿,
Nat. Clin. Pract. Cardiovasc. Med, 2006; 3; 499-506.
[9] Leeman E. et al., ￿E￿ective of acoustic conditions on microbubble-mediated microvascular
sonothrombolysis￿, Ultrasound in Med and Biol, 2012; Vol 38; 9; 1589-1598
[10] Janice L. Hinkle, ￿Acute Ischemic Stroke review￿, J Neurosci. Nurs., 2007; 39(5); 285-293, 310.
[11] Muir et al, ￿Imaging of acute stroke￿, Lancet Neurology, 2006; 5; 744￿768.
[12] Wolf-Dieter Heiss, ￿Systemic rtPA in Patients with Acute Ischemic Stroke￿, Max-
Planck-Institut f￿r neurologische Forschung, K￿ln, Germany [Online]. Available:
http://www.fac.org.ar/scvc/llave/stroke/heiss/heissi.htm (accessed 15-02-2013)
[13] Marler JR, ￿Tissue plasminogen activator for acute ischemic stroke￿, N Engl J Med; 1995; 333;
1581-1587
[14] Blakeley JO, Llinas RH. ￿Thrombolytic therapy for acute ischemic stroke￿. J.Neurol.Sci.
2007;261:55-62.
4950 BIBLIOGRAPHY
[15] H.P. Adams et al., ￿Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to
the Guidelines for the Management of Patients With Acute Ischemic Stroke A Statement for
Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart
Association￿ Stroke; a journal of cerebral circulation, 1996; 27; 1711-8.
[16] Robert J. Siegel, Huai Luo, ￿Ultrasound thrombolysis￿, Ultrasonics,2008; 48; 312-320
[17] Denise E et al., ￿Advancements in Catheter-Directed Ultrasound-Accelerated thrombolysis￿, J
Endvasc Ther, 2011; 18; 418-434
[18] Hirsh J et al., Executive summary: American College of Chest Physicians evidence-based
clinical practice guidelines (8th edition), Chest. ,2008; 133(6 SUPPL. 6); 110S-112S
[19] Hoskins P.R. et al., ￿Physiscs￿, in Diagnostic Ultrasound-Physics and equipment, London, UK,
GMM, 2003, ch 1, 7-22.
[20] Ultrasound - Technology INformation Portal, http://www.us-tip.com/serv1.php?type=db, last
update 22/04/2013 (accessed 07/06/2013)
[21] Greis, ￿Technology overview: SonoVue (Bracco, Milan)￿, Eur. Rad. Suppl, 2004;14[Suppl 8
];11-15.
[22] Shengping Qin et al.,￿Ultrasound contrast microbubbles in imaging and therapy: physis-
cal principles and engineering￿ Phys Med Biol, 2009; 54(6): R27. DOI:10.1088/0031-
9155/54/6/R01.
[23] Villanueva FS et al, ￿Targeted ultrasound imaging using microbubbles￿, Cardiol. Clin., 2004;
22(2); 283-98.
[24] Streeter Jason E. et al., ￿Improving sensitivity in ultrasound molecular imaging by tailoring
contrast agent size distribution: in vivo studies￿, Mol Imaging, 2010; 9(2); 87-95.
[25] Cavalieri et al., ￿Stable Polymeric Microballoons as Multifunctional Device for Biomedical
Uses: Synthesis and Characterization￿, Langmuir, 2005;21; 8758-8764.
[26] Kathryn E. Hitchcock and Christy K. Holland, ￿Ultrasound-Assisted Thrombolysis for Stroke
Therapy￿, Stroke, 2010;41; S50-S53.
[27] Francis CW et al., ￿Ultrasound accelerates transport of recombinant tissue plasminogen acti-
vator into clots￿ Ultrasound Med Biol., 1995; 21; 419-424.
[28] Saguchi T et al., ￿E￿ective and safe conditions of low frequency transcranial ultrasonic throm-
bolysis for acute ischemic stroke. Neurologica and histologic evaluation in a rat middle cerebral
artery stroke model￿, Stroke, 2008; 39;1007-1011.
[29] Tachibana K, Tachibana S., ￿Albumin microbubble echo-contrast material as an enhancer for
ultrasound accelerated thrombolysis￿, Circulation, 1995;92;1148-50.
[30] Schafer et al., ￿In￿uence of Ultrasound operating parameters on ultrasound-induced thrombol-
ysis in vitro￿, Ultrasound in Med. And Biol, 2005; vol 31, No 6; 841-847.BIBLIOGRAPHY 51
[31] Rosenschein U et al., ￿Study of the mechanism of ultrasound angioplasty from human thrombi
and bovine aorta￿ Am. J. Cardiol.,1994; 74; 1263-1266.
[32] Datta et al., ￿Correlation of cavitation with ultrasound enhancement of thrombolysis￿, Ultra-
sound Med Biol, 2006;32(8); 1257-1267.
[33] Collis et al., ￿ Cavitation microstreaming and stress ￿elds created by microbubbles￿, Ultrason-
ics, 2010;50; 273-279.
[34] Deng et al., ￿In vitro measurements of inertial cavitation thresholds in human blood￿, Ultra-
sound Med BIol, 1997; 23; 619-624.
[35] Borelli et al, ￿In￿uences of Microbubble Diameter and Ultrasonic Parameters on in Vitro
Sonothrombolysis E￿cacy￿, J Vasc Interv Radiol, 2012; 23; 1677-1684.
[36] Stefan Pfa￿enberger et al., ￿Ultrasound thrombolysis￿, Thromb Haemost, 2005;94; 26-36.
[37] Tachibana K., Tachibana S., ￿Enhancement of ￿brinolysis with ultrasound energy￿, J Vasc
Interv Radiol, 1992; 3; 299-303.
[38] Tachibana K., Tachibana S., ￿Prototype therapeutic ultrasound emitting catheter for acceler-
ating thrombolysis￿, J Ultrasound Med, 1997; 16; 529-35.
[39] Lynn JG et al., ￿A new method for the generation and use of focused ultrasound in experimental
biology￿, J Gen Physiol.,1942; 28; 179-193.
[40] Rosenschein et al., ￿Ultrasound Imaging-Guided Noninvasive Ultrasound Thrombolysis: Pre-
clinical Results￿, Circulation, 2000; 102; 238-245.
[41] Frenkel et al., ￿Pulsed High-Intensity Focused ultrasound Enhances Thrombolysis in an in-vitro
model￿, Radiology, 2006;239(1);86-93.
[42] Pfa￿enberger et al., ￿Can a Commercial Diagnostic Ultrasound Device Accelerate Thrombol-
ysis?: An in Vitro Skull Model￿, Stroke, 2005; 36; 124-128.
[43] Xie et al., ￿Treatment of Acute Intravascular Thrombi With Diagnostic Ultrasound and Intra-
venous Microbubbles￿, JACC Cardiovasc Imaging, 2009; 2(4); 511-8.
[44] Xie et al., ￿Diagnostic Ultrasound Combined with Glycoprotein 2b/3a Targeted Microbubbles
Improve Microvascular Recovery Following Acute Coronary Thrombotic Occlusions￿, Circula-
tion, 2009; 119(10); 1378-1385.
[45] Kutty et al., ￿Microbubble Mediated Thrombus Dissolution with Diagnostic Ultrasound for
the Threatment of Chronic Venous Thrombi￿, PloS One, 2012; 7(12); e51453.
[46] Nesser et al., ￿Therapeutic Ultrasound in Cardiology￿, Herz, 2002; 27; 269-278.
[47] Skoloudik et al., ￿Safety and e￿cacy of the sonographic acceleration of the middle cerebral
artery recanalization: results of the pilot thrombotripsy study￿, Ultrasound Med Biol, 2008;20;
58-6352 Appendix
[48] Bardon et al., ￿Safety and e￿cacy of sonothrombolysis using bilateral TCD monitor-
ing by diagnostic 2MHz probes- a pilot study￿, Biomed Pap Med Fac, 2012; 156; DOI:
10.5507/BP.2012.064.
[49] Rubiera et al., ￿Safety and E￿cacy of Ultrasound-Enhanced Thrombolysis: A Comprehensive
Review and Meta-Analysis of Randomized and Nonrandomized Studies￿, Stroke, 2010;41; 280-
287.
[50] Alexandrov et al., ￿A Pilot Randomized Clinical Safety Study of Sonothrombolysis Augumen-
tation With Ultrasound-Activated Per￿utre-Lipid Microspheres for Acute Ischemic Stroke￿,
Stroke, 2008;39(5); 1464-1469.
[51] Parikh et al., ￿Ultrasound-accelerated Thrombolysis for the treatment of Deep Vein Thrombo-
sis: Initial Clinical Experience￿, J Vasc Interv Radiol, 2008; 19; 521-528.
[52] Moskovitz, ￿Ultrasound Accelerated Thrombolysis: A Safe and E￿ective, Low-dose Throm-
bolytic Therapy for Acute Pulmonary Embolism￿, Vein, 2012; issue 3 volume 5.
[53] Malin Larsson et al., ￿Evaluation of the acoustic response of novel polymer-shelled contrast
agents using clinical ultrasound systems￿ , Submitted to Ultrasonics, 2013.
[54] Devcic-Kuhar, ￿In vitro thrombolysis enhanced by standing and travelling ultrasound wave
￿elds￿ Ultrasound in Med. & Biol., 2002;Vol. 28, No. 9, 1181￿1187.
[55] Xie et al., ￿E￿ect of Attenuationc and Thrombus Age on the Success of Ultrasound and Mi-
crobubble Mediated Thrombus Dissolution￿, Ultrasound Med. Biol.,2011, 37(2), 280-288;
[56] Melanie Pretzl and Barbara Cerroni, ￿Standard protocol: concentration of MB/ml￿, 3MiCRON
project, 2010.Appendix
1 % File name SetUpL12_5_50mmNoImaging1.m:
2 % code for Protocol 1
3 % frequency : 11.25MHz
4 % pulse length : 5ms
5 % max voltage : 100V
6 % time between trains of long pulses= 6s
7
8 clear all
9
10 % Specify system parameters .
11 Resource . Parameters . numTransmit = 128; % number of transmit channels .
12 Resource . Parameters . numRcvChannels = 128; % number of receive channels .
13 Resource . Parameters . speedOfSound = 1540; % speed of sound in m/sec
14 Resource . Parameters . simulateMode = 0; % 1=simulation ; 0=run with hardware
15 Resource . Parameters . fakeScanhead=1; % 1= run without probe
16
17 % Specify Trans structure array .
18 Trans .name = ’L12 5 50mm’ ; % L12 5 transducer is ’known ’
19 Trans . frequency = 9.0; % center frequency
20 Trans = computeTrans(Trans) ; % L12  5 transducer is ’known ’
21 Trans . maxHighVoltage = 50; % set a high voltage limit .
22 Trans . impedance = 45  60 i ; % set transducer impedance .
23
24 % Specify Media object . ’ pt1 .m’ script defines array of point targets .
25 pt1 ;
26 Media . function = ’ movePoints ’ ;
27
28 % Specify Resource .
29 Resource . RcvBuffer (1) . datatype = ’ int16 ’ ; % bit size of the sample
30 Resource . RcvBuffer (1) . rowsPerFrame = 4096; % size for acquisitions range
31 Resource . RcvBuffer (1) . colsPerFrame = Resource . Parameters . numRcvChannels ;
32 Resource . RcvBuffer (1) .numFrames = 1; % number of frames ( not used )
33
34 % Specify TW structure array .
35 TW(1) . type = ’ parametric ’ ; % waveform type
36 TW(1) . Parameters = [8 ,3 ,31 ,1]; % A=11.25 MHz, B =37%, C =1.4us , D= 1
37 TW(1) . extendBL = 1; % i f equal to 1 , C value multiplied by 64 thus C=88.18us
38
39 % Specify TX structure array .
40 TX(1) . waveform=1; % same waveform for all the elements
41 TX(1) . Origin =[0.0 ,0.0 ,0.0]; % beam origin
42 TX(1) . focus =60 ; %focus at 10 mm
43 TX(1) . aperture = 65; % tx aperture starts at element 65.
44 TX(1) .Apod =[zeros (1 ,36) ones (1 ,56) zeros (1 ,36) ] ;% tx from 56 elem
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45 TX(1) . Delay= computeTXDelays(TX(1) ) ; % delay for each active transmitter
46
47 % Specify Profile 5.
48 TPC(5) .name = ’ long pulse ’ ; % name of the profile
49 TPC(5) . maxHighVoltage = 50; % max voltage for the profile
50 TPC(5) . highVoltageLimit =50; % high voltage limit based on used model
51
52 % Specify TGC Waveform structure .
53 TGC. CntrlPts = [500 ,590 ,650 ,710 ,770 ,830 ,890 ,950]; % values already given
54 TGC. rangeMax = 185; % max depth of the range
55 TGC. Waveform = computeTGCWaveform(TGC) ; % use function already built in
56
57 % Specify Receive structure ( not used )
58 Receive .Apod= zeros (1 , Resource . Parameters . numRcvChannels) ;
59 Receive . aperture=1;
60 Receive . startDepth=2;
61 Receive . endDepth=185;
62 Receive .TGC=1;
63 Receive .mode=0;
64 Receive . bufnum=1;
65 Receive . framenum=1;
66 Receive .acqNum=1;
67 Receive . samplesPerWave=4;
68 Receive . InputFilter =[0.0036 ,0.0127 ,0.0066 ,  0.0881 ,  0.2595 ,0.6494];
69
70 % Specify SeqControl structure arrays .
71
72 % jump back to start .
73 SeqControl (1) .command = ’jump ’ ;
74 SeqControl (1) . argument = 2;
75 % Change to Profile 5 ( long pulse )
76 SeqControl (2) .command = ’ setTPCProfile ’ ;
77 SeqControl (2) . condition = ’ immediate ’ ;
78 SeqControl (2) . argument = 5;
79 % Set to allow time for profile change .
80 SeqControl (3) .command = ’noop ’ ;
81 SeqControl (3) . argument = 8000;% time in us
82 % Set time between long pulses .
83 SeqControl (4) .command = ’timeToNextAcq ’ ;
84 SeqControl (4) . argument = 124; % time in us
85 % Set 4s idle time (2 s more with SeqControl (7) )
86 SeqControl (5) .command = ’timeToNextAcq ’ ;
87 SeqControl (5) . argument = 4000000; % time in us
88 % Set return to MatLab
89 SeqControl (6) .command = ’ returnToMatlab ’ ;
90 % Set 0.5 s idle time ( used for having 2s more after SeqControl (5) )
91 SeqControl (7) .command = ’noop ’ ;
92 SeqControl (7) . argument = 500000 ; % time in us
93
94 % nsc is count of SeqControl objects
95 nsc = 8;
96
97 % n is count of Events
98 n = 1;
99
100 % Event for setting the profile 5
101 Event(n) . info = ’ set TPCProfile ’ ;
102 Event(n) . tx = 0; % no TXAppendix 55
103 Event(n) . rcv = 0; % no Rcv
104 Event(n) . recon = 0; % no Recon
105 Event(n) . process = 0; % no Processing
106 Event(n) . seqControl = [2 ,3]; % SeqControl (2) and SeqControl (3)
107 n=n+1;
108 % 40 Events for 5ms train of pulses
109 for i = 1: 40
110 Event(n) . info = ’ long pulse ’ ;
111 Event(n) . tx = 1; % use 1 st TX structure .
112 Event(n) . rcv = 0; % no Rcv
113 Event(n) . recon = 0; % no reconstruction .
114 Event(n) . process = 0; % no processing
115 Event(n) . seqControl = 4; % time between pulses
116 n = n+1;
117 end
118 % Idle time 4+2=6s and Return to Matlab
119 Event(n 1) . seqControl = [5 ,6];
120 for t=1:4
121 Event(n) . info=’ wait ’ ;
122 Event(n) . tx = 0; % no TX
123 Event(n) . rcv = 0; % no Rcv
124 Event(n) . recon = 0; % no Recon
125 Event(n) . process = 0; % no processing
126 Event(n) . seqControl = 7; % idle time
127 n=n+1;
128 end
129 % repeat sequence of events from second event
130 Event(n) . info = ’Jump back to second event ’ ;
131 Event(n) . tx = 0; % no TX
132 Event(n) . rcv = 0; % no Rcv
133 Event(n) . recon = 0; % no Recon
134 Event(n) . process = 0; % no processing
135 Event(n) . seqControl = 1;% jump command
136 n=n+1;
137 % sham events for VDAS running
138 Event(n) . info = ’sham event ’ ;
139 Event(n) . tx = 1; % no TX
140 Event(n) . rcv = 1; % no Rcv
141 Event(n) . recon = 0; % no Recon
142 Event(n) . process = 0; % no processing
143 Event(n) . seqControl = 0;
144 n=n+1;
145 Event(n) . info = ’sham event ’ ;
146 Event(n) . tx = 0; % no TX
147 Event(n) . rcv = 0; % no Rcv
148 Event(n) . recon = 0; % no Recon
149 Event(n) . process = 0; % no processing
150 Event(n) . seqControl = nsc ;
151 SeqControl ( nsc ) .command = ’ transferToHost ’ ;
152 nsc=nsc+1;
153
154 % Save all the structures to a .mat f i l e .
155 save ( ’L12 5_50mmNoImaging1 ’ ) ;56 Appendix
1 % File name SetUpL7_4NoImaging2_3 .m:
2 % code for Protocol 2 and for Protocol 3
3 % frequency : 4.09MHz
4 % pulse length : 5ms
5 % max voltage : 100V
6 % time between trains of long pulses= 6s
7
8 clear all
9
10 % Specify system parameters .
11 Resource . Parameters . numTransmit = 128; % number of transmit channels .
12 Resource . Parameters . numRcvChannels = 128; % number of receive channels .
13 Resource . Parameters . speedOfSound = 1540; % speed of sound in m/sec
14 Resource . Parameters . simulateMode = 0; % 1=simulation ; 0=run with hardware
15 Resource . Parameters . fakeScanhead=1; % 1= run without probe
16
17 % Specify Trans structure array .
18 Trans .name = ’L7 4 ’ ; % L7 4 transducer is ’known ’
19 Trans = computeTrans(Trans) ; % L7  4 transducer is ’known ’
20 Trans . maxHighVoltage = 50; % set a high voltage limit .
21
22
23 % only for simulation
24 % Specify Media object . ’ pt1 .m’ script defines array of point targets .
25 pt1 ;
26 Media . function = ’ movePoints ’ ;
27
28 % Specify Resource .
29 Resource . RcvBuffer (1) . datatype = ’ int16 ’ ; % bit size of the sample
30 Resource . RcvBuffer (1) . rowsPerFrame = 4096; % size for acquisitions range
31 Resource . RcvBuffer (1) . colsPerFrame = Resource . Parameters . numRcvChannels ;
32 Resource . RcvBuffer (1) .numFrames = 1; % number of frames ( not used )
33
34 % Specify TW structure array .
35 TW(1) . type = ’ parametric ’ ; % waveform type
36 TW(1) . Parameters = [22 ,8 ,31 ,1]; % A=4.09 MHz, B =37%, C =3.7us , D= 1
37 TW(1) . extendBL = 1; % i f equal to 1 , C value multiplied by 64 thus C=240us
38
39 % Specify TX structure array .
40 TX(1) . waveform=1; % same waveform for all the elements
41 TX(1) . Origin =[0.0 ,0.0 ,0.0]; % beam origin
42 TX(1) . focus =85 ; %focus at 25 mm
43 TX(1) .Apod =[zeros (1 ,44) ones (1 ,40) zeros (1 ,44) ] ;% tx from 40 elem
44 TX(1) . Delay= computeTXDelays(TX(1) ) ; % delay for each active transmitter
45
46 % Specify Profile 5.
47 TPC(5) .name = ’ long pulse ’ ; % name of the profile
48 TPC(5) . maxHighVoltage = 50; % max voltage for the profile
49 TPC(5) . highVoltageLimit =50; % high voltage limit based on used model
50
51 % Specify TGC Waveform structure .
52 TGC. CntrlPts = [500 ,590 ,650 ,710 ,770 ,830 ,890 ,950]; % values already given
53 TGC. rangeMax = 185; % max depth of the range
54 TGC. Waveform = computeTGCWaveform(TGC) ; % use function already built in
55
56 % Specify Receive structure ( not used )
57 Receive = repmat( struct ( . . .Appendix 57
58 ’Apod ’ , zeros (1 , Resource . Parameters . numRcvChannels) , . . .
59 ’ aperture ’ , 1 , . . .
60 ’ startDepth ’ , 2 , . . .
61 ’endDepth ’ , 185 , . . .
62 ’TGC’ , 1 , . . .
63 ’mode ’ , 0 , . . .
64 ’bufnum ’ , 1 , . . .
65 ’framenum ’ , 1 , . . .
66 ’acqNum ’ , 1 , . . .
67 ’samplesPerWave ’ , 4 , . . . ’ InputFilter ’
,[0.0036 ,0.0127 ,0.0066 ,  0.0881 ,  0.2595 ,0.6494]) , . . .
68 1 , Resource . RcvBuffer (1) .numFrames) ;
69
70 % Specify SeqControl structure arrays .
71
72 % jump back to start .
73 SeqControl (1) .command = ’jump ’ ;
74 SeqControl (1) . argument = 2;
75 % Change to Profile 5 ( long pulse )
76 SeqControl (2) .command = ’ setTPCProfile ’ ;
77 SeqControl (2) . condition = ’ immediate ’ ;
78 SeqControl (2) . argument = 5;
79 % Set to allow time for profile change .
80 SeqControl (3) .command = ’noop ’ ;
81 SeqControl (3) . argument = 8000;% time in us
82 % Set time between long pulses .
83 SeqControl (4) .command = ’timeToNextAcq ’ ;
84 SeqControl (4) . argument = 124; % time in us
85 % Set 4s idle time (2 s more with SeqControl (7) )
86 SeqControl (5) .command = ’timeToNextAcq ’ ;
87 SeqControl (5) . argument = 4000000; % time in us
88 % Set return to MatLab
89 SeqControl (6) .command = ’ returnToMatlab ’ ;
90 % Set 0.5 s idle time ( used for having 2s more after SeqControl (5) )
91 SeqControl (7) .command = ’noop ’ ;
92 SeqControl (7) . argument = 500000 ; % time in us
93
94 % nsc is count of SeqControl objects
95 nsc = 8;
96
97 % n is count of Events
98 n = 1;
99
100 % Event for setting the profile 5
101 Event(n) . info = ’ set TPCProfile ’ ;
102 Event(n) . tx = 0; % no TX
103 Event(n) . rcv = 0; % no Rcv
104 Event(n) . recon = 0; % no Recon
105 Event(n) . process = 0; % no Processing
106 Event(n) . seqControl = [2 ,3]; % SeqControl (2) and SeqControl (3)
107 n=n+1;
108 % 20 Events for 5ms train of pulses
109 for i = 1: 20
110 Event(n) . info = ’ long pulse ’ ;
111 Event(n) . tx = 1; % use 1 st TX structure .
112 Event(n) . rcv = 0; % no Rcv
113 Event(n) . recon = 0; % no reconstruction .
114 Event(n) . process = 0; % no processing58 Appendix
115 Event(n) . seqControl = 4; % time between pulses
116 n = n+1;
117 end
118 % Idle time 4+2=6s and Return to Matlab
119 Event(n 1) . seqControl = [5 ,6];
120 for t=1:4
121 Event(n) . info=’ wait ’ ;
122 Event(n) . tx = 0; % no TX
123 Event(n) . rcv = 0; % no Rcv
124 Event(n) . recon = 0; % no Recon
125 Event(n) . process = 0; % no processing
126 Event(n) . seqControl = 7; % idle time
127 n=n+1;
128 end
129 % repeat sequence of events from second event
130 Event(n) . info = ’Jump back to second event ’ ;
131 Event(n) . tx = 0; % no TX
132 Event(n) . rcv = 0; % no Rcv
133 Event(n) . recon = 0; % no Recon
134 Event(n) . process = 0; % no processing
135 Event(n) . seqControl = 1;% jump command
136 n=n+1;
137 % sham events for VDAS running
138 Event(n) . info = ’sham event ’ ;
139 Event(n) . tx = 1; % no TX
140 Event(n) . rcv = 1; % no Rcv
141 Event(n) . recon = 0; % no Recon
142 Event(n) . process = 0; % no processing
143 Event(n) . seqControl = 0;
144 n=n+1;
145 Event(n) . info = ’sham event ’ ;
146 Event(n) . tx = 0; % no TX
147 Event(n) . rcv = 0; % no Rcv
148 Event(n) . recon = 0; % no Recon
149 Event(n) . process = 0; % no processing
150 Event(n) . seqControl = nsc ;
151 SeqControl ( nsc ) .command = ’ transferToHost ’ ;
152 nsc=nsc+1;
153
154 % Save all the structures to a .mat f i l e .
155 save ( ’L7_4NoImaging2_3 ’ ) ;Appendix 59
1 % File name SetUpL7_4NoImaging4 .m:
2 % code for Protocol 4
3 % frequency : 4.09MHz
4 % pulse length : 10ms
5 % max voltage : 50V
6 % time between trains of long pulses= 6s
7
8 clear all
9
10 % Specify system parameters .
11 Resource . Parameters . numTransmit = 128; % number of transmit channels .
12 Resource . Parameters . numRcvChannels = 128; % number of receive channels .
13 Resource . Parameters . speedOfSound = 1540; % speed of sound in m/sec
14 Resource . Parameters . simulateMode = 0; % 1=simulation ; 0=run with hardware
15 Resource . Parameters . fakeScanhead=1; % 1= run without probe
16
17 % Specify Trans structure array .
18 Trans .name = ’L7 4 ’ ; % L7 4 transducer is ’known ’
19 Trans = computeTrans(Trans) ; % L7  4 transducer is ’known ’
20 Trans . maxHighVoltage = 25; % set a high voltage limit .
21
22
23 % only for simulation
24 % Specify Media object . ’ pt1 .m’ script defines array of point targets .
25 pt1 ;
26 Media . function = ’ movePoints ’ ;
27
28 % Specify Resource .
29 Resource . RcvBuffer (1) . datatype = ’ int16 ’ ; % bit size of the sample
30 Resource . RcvBuffer (1) . rowsPerFrame = 4096; % size for acquisitions range
31 Resource . RcvBuffer (1) . colsPerFrame = Resource . Parameters . numRcvChannels ;
32 Resource . RcvBuffer (1) .numFrames = 1; % number of frames ( not used )
33
34 % Specify TW structure array .
35 TW(1) . type = ’ parametric ’ ; % waveform type
36 TW(1) . Parameters = [22 ,8 ,31 ,1]; % A=4.09 MHz, B =37%, C =3.7us , D= 1
37 TW(1) . extendBL = 1; % i f equal to 1 , C value multiplied by 64 thus C=240us
38
39 % Specify TX structure array .
40 TX(1) . waveform=1; % same waveform for all the elements
41 TX(1) . Origin =[0.0 ,0.0 ,0.0]; % beam origin
42 TX(1) . focus =85 ; %focus at 25 mm
43 TX(1) .Apod =[zeros (1 ,44) ones (1 ,40) zeros (1 ,44) ] ;% tx from 40 elem
44 TX(1) . Delay= computeTXDelays(TX(1) ) ; % delay for each active transmitter
45
46 % Specify Profile 5.
47 TPC(5) .name = ’ long pulse ’ ; % name of the profile
48 TPC(5) . maxHighVoltage = 25; % max voltage for the profile
49 TPC(5) . highVoltageLimit =25; % high voltage limit based on used model
50
51 % Specify TGC Waveform structure .
52 TGC. CntrlPts = [500 ,590 ,650 ,710 ,770 ,830 ,890 ,950]; % values already given
53 TGC. rangeMax = 185; % max depth of the range
54 TGC. Waveform = computeTGCWaveform(TGC) ; % use function already built in
55
56 % Specify Receive structure ( not used )
57 Receive = repmat( struct ( . . .60 Appendix
58 ’Apod ’ , zeros (1 , Resource . Parameters . numRcvChannels) , . . .
59 ’ aperture ’ , 1 , . . .
60 ’ startDepth ’ , 2 , . . .
61 ’endDepth ’ , 185 , . . .
62 ’TGC’ , 1 , . . .
63 ’mode ’ , 0 , . . .
64 ’bufnum ’ , 1 , . . .
65 ’framenum ’ , 1 , . . .
66 ’acqNum ’ , 1 , . . .
67 ’samplesPerWave ’ , 4 , . . . ’ InputFilter ’
,[0.0036 ,0.0127 ,0.0066 ,  0.0881 ,  0.2595 ,0.6494]) , . . .
68 1 , Resource . RcvBuffer (1) .numFrames) ;
69
70 % Specify SeqControl structure arrays .
71
72 % jump back to start .
73 SeqControl (1) .command = ’jump ’ ;
74 SeqControl (1) . argument = 2;
75 % Change to Profile 5 ( long pulse )
76 SeqControl (2) .command = ’ setTPCProfile ’ ;
77 SeqControl (2) . condition = ’ immediate ’ ;
78 SeqControl (2) . argument = 5;
79 % Set to allow time for profile change .
80 SeqControl (3) .command = ’noop ’ ;
81 SeqControl (3) . argument = 8000;% time in us
82 % Set time between long pulses .
83 SeqControl (4) .command = ’timeToNextAcq ’ ;
84 SeqControl (4) . argument = 124; % time in us
85 % Set 4s idle time (2 s more with SeqControl (7) )
86 SeqControl (5) .command = ’timeToNextAcq ’ ;
87 SeqControl (5) . argument = 4000000; % time in us
88 % Set return to MatLab
89 SeqControl (6) .command = ’ returnToMatlab ’ ;
90 % Set 0.5 s idle time ( used for having 2s more after SeqControl (5) )
91 SeqControl (7) .command = ’noop ’ ;
92 SeqControl (7) . argument = 500000 ; % time in us
93
94 % nsc is count of SeqControl objects
95 nsc = 8;
96
97 % n is count of Events
98 n = 1;
99
100 % Event for setting the profile 5
101 Event(n) . info = ’ set TPCProfile ’ ;
102 Event(n) . tx = 0; % no TX
103 Event(n) . rcv = 0; % no Rcv
104 Event(n) . recon = 0; % no Recon
105 Event(n) . process = 0; % no Processing
106 Event(n) . seqControl = [2 ,3]; % SeqControl (2) and SeqControl (3)
107 n=n+1;
108 % 40 Events for 10ms train of pulses
109 for i = 1: 40
110 Event(n) . info = ’ long pulse ’ ;
111 Event(n) . tx = 1; % use 1 st TX structure .
112 Event(n) . rcv = 0; % no Rcv
113 Event(n) . recon = 0; % no reconstruction .
114 Event(n) . process = 0; % no processingAppendix 61
115 Event(n) . seqControl = 4; % time between pulses
116 n = n+1;
117 end
118 % Idle time 4+2=6s and Return to Matlab
119 Event(n 1) . seqControl = [5 ,6];
120 for t=1:4
121 Event(n) . info=’ wait ’ ;
122 Event(n) . tx = 0; % no TX
123 Event(n) . rcv = 0; % no Rcv
124 Event(n) . recon = 0; % no Recon
125 Event(n) . process = 0; % no processing
126 Event(n) . seqControl = 7; % idle time
127 n=n+1;
128 end
129 % repeat sequence of events from second event
130 Event(n) . info = ’Jump back to second event ’ ;
131 Event(n) . tx = 0; % no TX
132 Event(n) . rcv = 0; % no Rcv
133 Event(n) . recon = 0; % no Recon
134 Event(n) . process = 0; % no processing
135 Event(n) . seqControl = 1;% jump command
136 n=n+1;
137 % sham events for VDAS running
138 Event(n) . info = ’sham event ’ ;
139 Event(n) . tx = 1; % no TX
140 Event(n) . rcv = 1; % no Rcv
141 Event(n) . recon = 0; % no Recon
142 Event(n) . process = 0; % no processing
143 Event(n) . seqControl = 0;
144 n=n+1;
145 Event(n) . info = ’sham event ’ ;
146 Event(n) . tx = 0; % no TX
147 Event(n) . rcv = 0; % no Rcv
148 Event(n) . recon = 0; % no Recon
149 Event(n) . process = 0; % no processing
150 Event(n) . seqControl = nsc ;
151 SeqControl ( nsc ) .command = ’ transferToHost ’ ;
152 nsc=nsc+1;
153
154 % Save all the structures to a .mat f i l e .
155 save ( ’L7_4NoImaging4 ’ ) ;62 Appendix
1 % File name SetUpL12_5_50mmImaging .m:
2 % code for sending long pulses with imaging in between
3 % adapted from the Verasonic script SetUpL12_5_50mmFlash_4B.m
4 % LONG PULSES:
5 %   frequency : 11.25MHz
6 %   voltage : 100V
7 %   pulse length : 88.18 us / idle time : 35.82 us
8 %   train of pulses length : 5ms / idle time : 6s
9 % IMAGING:
10 %   frequency : 11.25MHz
11 %   voltage : 3V
12 %   pulse length 0.08 us
13 %   three apertures
14 % 128 transmit channels are used for each of 3 transmit apertures . On receive , the
15 % 128 channels are positioned as follows ( each char represents 4 elements ) :
16 % IMAGING
17 %
18 % Element Nos . 1 1 1 2
19 % 6 8 2 7 9 5
20 % 1 5 6 9 2 3 6
21 % Aperture 1: | | | | | | |
22 % t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t                                 
23 % r r r r r r r r r r r r r r r r r r r r r                                            
24 % | | | | | | |
25 % Aperture 2: | | | | | | |
26 %                 t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t                 
27 %                      r r r r r r r r r r r r r r r r r r r r r r                      
28 % | | | | | | |
29 % Aperture 3: | | | | | | |
30 %                                 t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t
31 %                                            r r r r r r r r r r r r r r r r r r r r r
32 % | | | | | | |
33 %
34 % The receive data from each of these apertures are stored under different acqNums
in the
35 % Receive buffer . The reconstruction sums the IQ data from the 3 aquisitions and
computes
36 % intensity values to produce the f u l l frame .
37 %
38 % This version does asynchronous acquisition and processing .
39 %PULSE TRANSMISSION
40 % Aperture 1: | | | | | | |
41 %                 t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t                 
42
43
44 clear all
45
46 % Specify system parameters .
47 Resource . Parameters . numTransmit = 128; % number of transmit channels .
48 Resource . Parameters . numRcvChannels = 128; % number of receive channels .
49 Resource . Parameters . speedOfSound = 1540; % set speed of sound in m/sec
50 Resource . Parameters . simulateMode = 0;
51 Resource . Parameters . fakeScanhead=1;
52
53 % Specify Trans structure array .
54 Trans .name = ’L12 5 50mm’ ;
55 Trans . frequency = 9.0;Appendix 63
56 Trans = computeTrans(Trans) ; % L12  5 transducer is ’known ’
57 Trans . maxHighVoltage = 50;
58 Trans . impedance = 45  60 i ;
59
60 % Specify SFormat structure array .
61 SFormat . transducer = ’L12 5 50mm’ ;
62 SFormat . scanFormat = ’RLIN ’ ; % rectangular linear array scan
63 SFormat . radius = 0;
64 SFormat . theta = 0;
65 SFormat .numRays = 1; % Flat Focus
66 SFormat . FirstRayLoc = [0 ,0 ,0]; % x ,y , z
67 SFormat . rayDelta = 256 *Trans . spacing ; % spacing in dist . between rays
68 SFormat . startDepth = 2; % Acquisition start depth in wavelength
69 SFormat . endDepth = 185 ; % Acquisition end depth in wavelength
70
71 % Specify PData structure array .
72 PData . sFormat = 1; % use f i r s t SFormat structure .
73 PData . pdeltaX = 1.0;
74 PData . pdeltaZ = 0.5;
75 PData . Size (1) = c e i l (( SFormat . endDepth  SFormat . startDepth )/PData . pdeltaZ ) ;
76 PData . Size (2) = c e i l (( Trans . numelements *Trans . spacing )/PData . pdeltaX ) ;
77 PData . Size (3) = 1; % single image page
78 PData . Origin = [  Trans . spacing *(Trans . numelements  1)/2 ,0 ,SFormat . startDepth ] ;
79
80 % only for simulation
81 % Specify Media object . ’ pt1 .m’ script defines array of point targets .
82 pt1 ;
83 Media . function = ’ movePoints ’ ;
84
85 % Specify Resources .
86 Resource . RcvBuffer (1) . datatype = ’ int16 ’ ;
87 Resource . RcvBuffer (1) . rowsPerFrame = 4096 *3; % this size allows for 3 acqs ,
maximum range
88 Resource . RcvBuffer (1) . colsPerFrame = Resource . Parameters . numRcvChannels ;
89 Resource . RcvBuffer (1) .numFrames = 245; % allows 5s of imaging
90 Resource . InterBuffer (1) . datatype = ’complex ’ ;
91 Resource . InterBuffer (1) . rowsPerFrame = 1024; % this is for greatest depth
92 Resource . InterBuffer (1) . colsPerFrame = PData . Size (2) ;
93 Resource . InterBuffer (1) .numFrames = 1; % one intermediate buffer needed .
94 Resource . ImageBuffer (1) . datatype = ’ double ’ ;
95 Resource . ImageBuffer (1) . rowsPerFrame = 1024;
96 Resource . ImageBuffer (1) . colsPerFrame = PData . Size (2) ;
97 Resource . ImageBuffer (1) .numFrames = 10;
98 Resource . DisplayWindow (1) . Title = ’Image Display ’ ;
99 Resource . DisplayWindow (1) . pdelta = 0.45;
100 Resource . DisplayWindow (1) . Position = [250 ,250 , . . . % upper l e f t corner position
101 c e i l (PData . Size (2) *PData . pdeltaX/Resource . DisplayWindow (1) . pdelta ) , . . . %
width
102 c e i l (PData . Size (1) *PData . pdeltaZ/Resource . DisplayWindow (1) . pdelta ) ] ; %
height
103 Resource . DisplayWindow (1) . ReferencePt = [ PData . Origin (1) ,PData . Origin (3) ] ; % 2D
imaging (X,Z plane )
104 Resource . DisplayWindow (1) . Colormap = gray (256) ;
105
106 % Specify Transmit waveform structure .
107 % for imaging
108 TW(1) . type = ’ parametric ’ ;
109 TW(1) . Parameters = [8 ,4 ,2 ,1]; % A=11.25MHz, B =50%, C =0.08us , D= 164 Appendix
110 % for long pulses
111 TW(2) . type = ’ parametric ’ ;
112 TW(2) . Parameters = [8 ,3 ,31 ,1]; % A=11.25MHz, B =37%, C =88.18us , D= 1
113 TW(2) . extendBL = 1;
114
115 % Specify TX structure array .
116 % imaging
117 TX = repmat( struct ( ’waveform ’ , 1 , . . .
118 ’ Origin ’ , [0.0 ,0.0 ,0.0] , . . .
119 ’ aperture ’ , 1 , . . .
120 ’Apod ’ , ones (1 , Resource . Parameters . numTransmit) , . . .
121 ’ focus ’ , 0.0 , . . .
122 ’ Steer ’ , [0.0 ,0.0] , . . .
123 ’ Delay ’ , zeros (1 , Resource . Parameters . numTransmit) ) , 1 , 4) ;
124 TX(2) . aperture = 65; % Use the tx aperture that starts at element 65.
125 TX(3) . aperture = 129; % Use the tx aperture that starts at element 129.
126 % for long pulses
127 TX(4) . waveform = 2;
128 TX(4) . aperture = 65;
129 TX(4) .Apod =[zeros (1 ,36) ones (1 ,56) zeros (1 ,36) ] ;
130 TX(4) . focus =60 ; %focus at 10mm
131 TX(4) . Delay= computeTXDelays(TX(4) ) ;
132
133 % Specify TGC Waveform structure .
134 TGC. CntrlPts = [500 ,590 ,650 ,710 ,770 ,830 ,890 ,950];
135 TGC. rangeMax = SFormat . endDepth ;
136 TGC. Waveform = computeTGCWaveform(TGC) ;
137
138 % Specify TPC structures .
139 % profile 1 for imaging
140 TPC(1) .name = ’2D’ ;
141 TPC(1) . maxHighVoltage = 50;
142 TPC(1) . highVoltageLimit = 50;
143 % profile 5 for long pulses
144 TPC(5) .name = ’ long pulse ’ ;
145 TPC(5) . maxHighVoltage = 50;
146 TPC(5) . highVoltageLimit =50;
147
148 % Specify Receive structure arrays  
149 % endDepth   add additional acquisition depth to account for some channels
150 % having longer path lengths .
151 % InputFilter   The same coefficients are used for all channels . The
152 % coefficients below give a broad bandwidth bandpass f i l t e r .
153 maxAcqLength = sqrt (SFormat . endDepth^2 + (Trans . numelements *Trans . spacing )^2)  
SFormat . startDepth ;
154 wlsPer128 = 128/(4 *2) ; % wavelengths in 128 samples for 4 samplesPerWave
155 Receive = repmat( struct ( ’Apod ’ , zeros (1 , Resource . Parameters . numRcvChannels) , . . .
156 ’ aperture ’ , 1 , . . .
157 ’ startDepth ’ , SFormat . startDepth , . . .
158 ’endDepth ’ , SFormat . startDepth + wlsPer128 * c e i l (
maxAcqLength/wlsPer128 ) , . . .
159 ’TGC’ , 1 , . . .
160 ’bufnum ’ , 1 , . . .
161 ’framenum ’ , 1 , . . .
162 ’acqNum ’ , 1 , . . .
163 ’samplesPerWave ’ , 4 , . . .
164 ’mode ’ , 0 , . . .
165 ’ InputFilter ’Appendix 65
,[0.0036 ,0.0127 ,0.0066 ,  0.0881 ,  0.2595 ,0.6494] , . . .
166 ’ callMediaFunc ’ , 0) ,1 ,3 *( Resource . RcvBuffer (1) .numFrames) ) ;
167
168 %   Set event specific Receive attributes .
169 for i = 1: Resource . RcvBuffer (1) .numFrames % 3 acquisitions per frame
170 %    1 st synthetic aperture acquisition for aperture 1.
171 Receive (3* i  2) .Apod(1:85) = 1.0;
172 Receive (3* i  2) . aperture = 1;
173 Receive (3* i  2) . framenum = i ;
174 Receive (3* i  2) .acqNum = 1;
175 Receive (3* i  2) . callMediaFunc = 1;
176 %    2nd synthetic aperture acquisition for aperture 65.
177 Receive (3* i  1) .Apod(22:107) = 1.0;
178 Receive (3* i  1) . aperture = 65;
179 Receive (3* i  1) . framenum = i ;
180 Receive (3* i  1) .acqNum = 2;
181 %    3rd synthetic aperture acquisition for aperture 129.
182 Receive (3* i ) .Apod(44:128) = 1.0;
183 Receive (3* i ) . aperture = 129;
184 Receive (3* i ) . framenum = i ;
185 Receive (3* i ) .acqNum = 3;
186 end
187
188 % Specify Recon structure arrays .
189 Recon = struct ( ’ senscutoff ’ , 0.6 , . . .
190 ’pdatanum ’ , 1 , . . .
191 ’rcvBufFrame ’ ,  1, . . . % use most recently transferred frame
192 ’ IntBufDest ’ , [1 ,1] , . . .
193 ’ImgBufDest ’ , [1 ,  1] , . . . % auto increment ImageBuffer each recon
194 ’RINums ’ , [ 1 ; 2 ; 3 ] ) ;
195
196 % Define ReconInfo structures .
197 ReconInfo = repmat( struct ( ’mode ’ , 3 , . . . % replace IQ data .
198 ’txnum ’ , 1 , . . .
199 ’rcvnum ’ , 1 , . . .
200 ’regionnum ’ , 0) , 1 , 3) ;
201 %   Set specific ReconInfo attributes .
202 ReconInfo (2) .mode = 4; % accumulate and detect IQ data in output buffer .
203 ReconInfo (2) .txnum = 2;
204 ReconInfo (2) . rcvnum = 2;
205 ReconInfo (3) .mode = 5; % accumulate and detect IQ data in output buffer .
206 ReconInfo (3) .txnum = 3;
207 ReconInfo (3) . rcvnum = 3;
208
209 % Specify Process structure array .
210 pers = 30;
211 Process (1) . classname = ’Image ’ ;
212 Process (1) . method = ’ imageDisplay ’ ;
213 Process (1) . Parameters = { ’imgbufnum ’ , 1 , . . . % number of buffer to process .
214 ’framenum ’ ,  1 ,... % ( 1 = lastFrame )
215 ’pdatanum ’ , 1 , . . . % number of PData structure to use
216 ’norm ’ , 1 , . . . % normalization method(1 means fixed )
217 ’ pgain ’ , 1 . 0 , . . . % pgain is image processing gain
218 ’ persistMethod ’ , ’ simple ’ , . . .
219 ’ persistLevel ’ , pers , . . .
220 ’ interp ’ , 1 , . . . % method of interpolation (1=4pt interp )
221 ’ compression ’ , 0 . 5 , . . .% X^0.5 normalized to output word
size66 Appendix
222 ’ reject ’ , 2 , . . .
223 ’mappingMode ’ , ’ f u l l ’ , . . .
224 ’ display ’ , 1 , . . . % display image after processing
225 ’displayWindow ’ ,1};
226
227 % Specify SeqControl structure arrays .
228
229 % jump back to start
230 SeqControl (1) .command = ’jump ’ ;
231 SeqControl (1) . argument = 1;
232 % set profile 1
233 SeqControl (2) .command = ’ setTPCProfile ’ ;
234 SeqControl (2) . condition = ’ immediate ’ ;
235 SeqControl (2) . argument = 1;
236 % set profile 5
237 SeqControl (3) .command = ’ setTPCProfile ’ ;
238 SeqControl (3) . condition = ’ immediate ’ ;
239 SeqControl (3) . argument = 5;
240 % allow time for switchin to profile 5
241 SeqControl (4) .command = ’noop ’ ;
242 SeqControl (4) . argument = 8000; % time in us
243 % time between long pulses
244 SeqControl (5) .command = ’timeToNextAcq ’ ;
245 SeqControl (5) . argument = 124; % time in usec
246 % 1s not imaging and not transmitting long pulse
247 SeqControl (6) .command = ’timeToNextAcq ’ ;
248 SeqControl (6) . argument = 1000000; % 1s
249 % return to MatLab
250 SeqControl (7) .command = ’ returnToMatlab ’ ;
251 % time between apertures for imaging
252 SeqControl (8) .command = ’timeToNextAcq ’ ;
253 SeqControl (8) . argument = 200; % 200 usec
254 % time between frames for imaging
255 SeqControl (9) .command = ’timeToNextAcq ’ ;
256 SeqControl (9) . argument = 20000; % 20ms
257
258 % nsc is count of SeqControl objects
259 nsc = 10;
260
261 % n is count of Events
262 n = 1;
263
264 Event(n) . info = ’ set TPCProfile ’ ;
265 Event(n) . tx = 0; % no TX
266 Event(n) . rcv = 0; % no Rcv
267 Event(n) . recon = 0; % no Recon
268 Event(n) . process = 0;
269 Event(n) . seqControl = [ 2 ] ;
270 n=n+1;
271 % Acquire all frames defined in RcvBuffer
272 for i = 1: Resource . RcvBuffer (1) .numFrames
273 i f i==Resource . RcvBuffer (1) .numFrames
274 Event(n) . info = ’ set TPCProfile ’ ;
275 Event(n) . tx=0; % no tx
276 Event(n) . rcv=0; % no rcv
277 Event(n) . recon = 0; % no reconstruction .
278 Event(n) . process = 0; % no processing
279 Event(n) . seqControl =[3 ,4];Appendix 67
280 n=n+1;
281 for t= 1:40
282 Event(n) . info=’ transmit long pulse ’ ;
283 Event(n) . tx=4;
284 Event(n) . rcv=0; % no rcv
285 Event(n) . recon = 0; % no reconstruction .
286 Event(n) . process = 0; % no processing
287 Event(n) . seqControl = 5;
288 n=n+1;
289 end
290 Event(n 1) . seqControl = 6;
291 Event(n) . info=’ return to Matlab ’ ;
292 Event(n) . tx=0;
293 Event(n) . rcv=0;
294 Event(n) . recon = 0; % no reconstruction .
295 Event(n) . process = 0; % no processing
296 Event(n) . seqControl = 7;
297 n=n+1;
298 else
299 Event(n) . info = ’1 st 3rd of aperture . ’ ;
300 Event(n) . tx = 1; % use 1 st TX structure .
301 Event(n) . rcv = 3*i  2; % use 1 st Rcv structure .
302 Event(n) . recon = 0; % no reconstruction .
303 Event(n) . process = 0; % no processing
304 Event(n) . seqControl = 8; % time between syn . aper . acqs .
305 n = n+1;
306
307 Event(n) . info = ’ middle 3rd of aperture . ’ ;
308 Event(n) . tx = 2; % use 1 st TX structure .
309 Event(n) . rcv = 3*i  1; % use 1 st Rcv structure .
310 Event(n) . recon = 0; % no reconstruction .
311 Event(n) . process = 0; % no processing
312 Event(n) . seqControl = 8; % time between syn . aper . acqs .
313 n = n+1;
314 Event(n) . info = ’ last 3rd of aperture . ’ ;
315 Event(n) . tx = 3; % use 3rd TX structure .
316 Event(n) . rcv = 3* i ; % use 3rd Rcv structure .
317 Event(n) . recon = 0; % no reconstruction .
318 Event(n) . process = 0; % no processing
319 Event(n) . seqControl = [9 , nsc ] ; % use SeqControl structs defined below .
320 SeqControl ( nsc ) .command = ’ transferToHost ’ ;
321 nsc = nsc + 1;
322 n = n+1;
323
324 Event(n) . info = ’ Reconstruct ’ ;
325 Event(n) . tx = 0; % no transmit
326 Event(n) . rcv = 0; % no rcv
327 Event(n) . recon = 1; % reconstruction
328 Event(n) . process = 1; % processing
329 i f floor ( i /5) == i /5 % Exit to Matlab every 5th frame
330 Event(n) . seqControl = 7; % return to Matlab
331 else
332 Event(n) . seqControl = 0;
333 end
334 n = n+1;
335 end
336 end
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338
339
340 Event(n) . info = ’Jump ’ ;
341 Event(n) . tx = 0; % no TX
342 Event(n) . rcv = 0; % no Rcv
343 Event(n) . recon = 0; % no Recon
344 Event(n) . process = 0; % no process
345 Event(n) . seqControl = 1; % jump command
346 n=n+1;
347 Event(n) . info = ’sham event ’ ;
348 Event(n) . tx = 1;
349 Event(n) . rcv = 1;
350 Event(n) . recon = 0; % no Recon
351 Event(n) . process = 0; % no process
352 Event(n) . seqControl = 0;
353 n=n+1;
354 Event(n) . info = ’sham event ’ ;
355 Event(n) . tx = 0; % no TX
356 Event(n) . rcv = 0; % no Rcv
357 Event(n) . recon = 0; % no Recon
358 Event(n) . process = 0; % no process
359 Event(n) . seqControl = nsc ;
360 SeqControl ( nsc ) .command = ’ transferToHost ’ ;
361 nsc=nsc+1;
362
363
364
365 % User specified UI Control Elements
366 %   Sensitivity Cutoff
367 sensx = 170;
368 sensy = 420;
369 UI(1) . Control = { ’ Style ’ , ’ text ’ , . . . % popupmenu gives l i s t of choices
370 ’ String ’ , ’ Sens . Cutoff ’ , . . .
371 ’ Position ’ ,[ sensx+10,sensy ,100 ,20] ,... % position on UI
372 ’FontName ’ , ’ Arial ’ , ’FontWeight ’ , ’ bold ’ , ’ FontSize ’ ,12 ,...
373 ’ BackgroundColor ’ ,[0.8 ,0.8 ,0.8]};
374
375 UI(2) . Control = { ’ Style ’ , ’ slider ’ , . . . % popupmenu gives l i s t of choices
376 ’ Position ’ ,[ sensx , sensy  30 ,120 ,30] ,... % position on UI
377 ’Max’ ,1.0 , ’Min ’ ,0 , ’Value ’ ,Recon(1) . senscutoff , . . .
378 ’ SliderStep ’ ,[0.025 0 . 1 ] , . . .
379 ’Tag ’ , ’ sensSlider ’ , . . .
380 ’ Callback ’ ,{ @sensCutoffCallback }};
381 UI(2) . Callback = { ’ sensCutoffCallback .m’ , . . .
382 ’ function sensCutoffCallback (hObject , eventdata ) ’ , . . .
383 ’ ’ , . . .
384 ’ sens = get (hObject , ’ ’Value ’ ’ ) ; ’ , . . .
385 ’ReconL = evalin ( ’ ’ base ’ ’ , ’ ’Recon ’ ’ ) ; ’ , . . .
386 ’ for i = 1: size (ReconL ,2) ’ , . . .
387 ’ ReconL( i ) . senscutoff = sens ; ’ , . . .
388 ’end ’ , . . .
389 ’ assignin ( ’ ’ base ’ ’ , ’ ’Recon ’ ’ ,ReconL) ; ’ , . . .
390 ’% Set Control .Command to re  i n i t i a l i z e Recon structure . ’ , . . .
391 ’ Control = evalin ( ’ ’ base ’ ’ , ’ ’ Control ’ ’ ) ; ’ , . . .
392 ’ Control .Command = ’ ’ update&Run ’ ’ ; ’ , . . .
393 ’ Control . Parameters = { ’ ’Recon ’ ’ }; ’ , . . .
394 ’ assignin ( ’ ’ base ’ ’ , ’ ’ Control ’ ’ , Control ) ; ’ , . . .
395 ’% Set the new cutoff value in the text f i e l d . ’ , . . .Appendix 69
396 ’h = findobj ( ’ ’ tag ’ ’ , ’ ’ sensCutoffValue ’ ’ ) ; ’ , . . .
397 ’ set (h , ’ ’ String ’ ’ ,num2str( sens , ’ ’%1.3 f ’ ’ ) ) ; ’ , . . .
398 ’ return ’ };
399
400 UI(3) . Control = { ’ Style ’ , ’ edit ’ , ’ String ’ ,num2str(Recon(1) . senscutoff , ’%1.3 f ’ ) , . . .
%text
401 ’ Position ’ ,[ sensx+20,sensy  40 ,60 ,22] , . . . % position on UI
402 ’ tag ’ , ’ sensCutoffValue ’ , . . .
403 ’ BackgroundColor ’ , [ 0 . 9 , 0 . 9 , 0 . 9 ] , . . .
404 ’ Callback ’ ,{ @sensCutOffValueCallback }};
405
406 UI(3) . Callback = { ’ sensCutOffValueCallback .m’ , . . .
407 ’ function sensCutOffValueCallback (hObject , eventdata ) ’ , . . .
408 ’ ’ , . . .
409 ’ sens = str2num( get (hObject , ’ ’ String ’ ’ ) ) ; ’ , . . .
410 ’ReconL = evalin ( ’ ’ base ’ ’ , ’ ’Recon ’ ’ ) ; ’ , . . .
411 ’ for i = 1: size (ReconL ,2) ’ , . . .
412 ’ ReconL( i ) . senscutoff = sens ; ’ , . . .
413 ’end ’ , . . .
414 ’ assignin ( ’ ’ base ’ ’ , ’ ’Recon ’ ’ ,ReconL) ; ’ , . . .
415 ’% Set Control .Command to re  i n i t i a l i z e Recon structure . ’ , . . .
416 ’ Control = evalin ( ’ ’ base ’ ’ , ’ ’ Control ’ ’ ) ; ’ , . . .
417 ’ Control .Command = ’ ’ update&Run ’ ’ ; ’ , . . .
418 ’ Control . Parameters = { ’ ’Recon ’ ’ }; ’ , . . .
419 ’ assignin ( ’ ’ base ’ ’ , ’ ’ Control ’ ’ , Control ) ; ’ , . . .
420 ’% Set the new cutoff value for the slider ’ , . . .
421 ’ set ( findobj ( ’ ’Tag ’ ’ , ’ ’ sensSlider ’ ’ ) , ’ ’Value ’ ’ , sens ) ; ’ , . . .
422 ’ return ’ };
423
424
425 %   Range Change
426 rngx = 20;
427 rngy = 125;
428 UI(4) . Control = { ’ Style ’ , ’ text ’ , ’ String ’ , ’Range ’ , . . .
429 ’ Position ’ ,[ rngx+10,rngy , 8 0 , 2 0 ] , . . .
430 ’FontName ’ , ’ Arial ’ , ’FontWeight ’ , ’ bold ’ , ’ FontSize ’ ,12 ,...
431 ’ BackgroundColor ’ ,[0.8 ,0.8 ,0.8]};
432
433 UI(5) . Control = { ’ Style ’ , ’ slider ’ , . . .
434 ’ Position ’ ,[ rngx , rngy  30 ,120 ,30] ,...
435 ’Max’ ,320 , ’Min ’ ,64 , ’Value ’ ,SFormat . endDepth , . . .
436 ’ SliderStep ’ , [ 0 . 1 , 0 . 2 ] , . . .
437 ’ Callback ’ ,{ @rangeChangeCallback }};
438
439 UI(5) . Callback = { ’ rangeChangeCallback .m’ , . . .
440 ’ function rangeChangeCallback (hObject , eventdata ) ’ , . . .
441 ’ ’ , . . .
442 ’simMode = evalin ( ’ ’ base ’ ’ , ’ ’ Resource . Parameters . simulateMode ’ ’ ) ; ’ , . . .
443 ’% No range change i f in simulate mode 2. ’ , . . .
444 ’ i f simMode == 2 ’ , . . .
445 ’ set (hObject , ’ ’Value ’ ’ , evalin ( ’ ’ base ’ ’ , ’ ’SFormat . endDepth ’ ’ ) ) ; ’ , . . .
446 ’ return ’ , . . .
447 ’end ’ , . . .
448 ’ range = get (hObject , ’ ’Value ’ ’ ) ; ’ , . . .
449 ’ assignin ( ’ ’ base ’ ’ , ’ ’ range ’ ’ , range ) ; ’ , . . .
450 ’SFormat = evalin ( ’ ’ base ’ ’ , ’ ’SFormat ’ ’ ) ; ’ , . . .
451 ’SFormat . endDepth = range ; ’ , . . .
452 ’ assignin ( ’ ’ base ’ ’ , ’ ’SFormat ’ ’ ,SFormat) ; ’ , . . .70 Appendix
453 ’ evalin ( ’ ’ base ’ ’ , ’ ’PData . Size (1)=c e i l (( SFormat . endDepth  SFormat . startDepth
)/PData . pdeltaZ ) ; ’ ’ ) ; ’ , . . .
454 ’ evalin ( ’ ’ base ’ ’ , ’ ’ [ PData . Region , PData . numRegions ] = createRegions (PData) ;
’ ’ ) ; ’ , . . .
455 ’ evalin ( ’ ’ base ’ ’ , ’ ’ Resource . DisplayWindow (1) . Position (4) =
456 c e i l (PData . Size (1) *PData . pdeltaZ/Resource . DisplayWindow (1) . pdelta ) ; ’ ’ ) ; ’
, . . .
457 ’ Receive = evalin ( ’ ’ base ’ ’ , ’ ’ Receive ’ ’ ) ; ’ , . . .
458 ’Trans = evalin ( ’ ’ base ’ ’ , ’ ’Trans ’ ’ ) ; ’ , . . .
459 ’maxAcqLength=sqrt ( range^2+(Trans . numelements *Trans . spacing )^2) SFormat .
startDepth ; ’ , . . .
460 ’ wlsPer128 = 128/(4 *2) ; ’ , . . .
461 ’ for i = 1: size ( Receive ,2) ’ , . . .
462 ’ Receive ( i ) . endDepth=SFormat . startDepth+wlsPer128 * c e i l (maxAcqLength/
wlsPer128 ) ; ’ , . . . ’end ’ , . . .
463 ’ assignin ( ’ ’ base ’ ’ , ’ ’ Receive ’ ’ , Receive ) ; ’ , . . .
464 ’% Update VDAS parameters of Receive objects . ’ , . . .
465 ’ evalin ( ’ ’ base ’ ’ , ’ ’updateVDAS( ’ ’ ’ ’ Receive ’ ’ ’ ’ ) ’ ’ ) ; ’ , . . .
466 ’ evalin ( ’ ’ base ’ ’ , ’ ’TGC. rangeMax = SFormat . endDepth ; ’ ’ ) ; ’ , . . .
467 ’ evalin ( ’ ’ base ’ ’ , ’ ’TGC. Waveform = computeTGCWaveform(TGC) ; ’ ’ ) ; ’ , . . .
468 ’ Control = evalin ( ’ ’ base ’ ’ , ’ ’ Control ’ ’ ) ; ’ , . . .
469 ’ Control .Command = ’ ’ update&Run ’ ’ ; ’ , . . .
470 ’ Control . Parameters = { ’ ’SFormat ’ ’ , ’ ’PData ’ ’ , ’ ’ Receive ’ ’ , ’ ’Recon
’ ’ , ’ ’DisplayWindow ’ ’ , ’ ’ ImageBuffer ’ ’ }; ’ ,. . .
471 ’ assignin ( ’ ’ base ’ ’ , ’ ’ Control ’ ’ , Control ) ; ’ , . . .
472 ’ assignin ( ’ ’ base ’ ’ , ’ ’ action ’ ’ , ’ ’ displayChange ’ ’ ) ; ’ , . . .
473 ’h = findobj ( ’ ’ tag ’ ’ , ’ ’ rangeValue ’ ’ ) ; ’ , . . .
474 ’ set (h , ’ ’ String ’ ’ ,num2str( range , ’ ’%3.0 f ’ ’ ) ) ; ’ , . . .
475 ’ return ’ };
476
477
478 UI(6) . Control = { ’ Style ’ , ’ edit ’ , ’ String ’ ,num2str(SFormat . endDepth , ’%3.0 f ’ ) , . . .%
text
479 ’ Position ’ ,[ rngx+20,rngy  40 ,60 ,22] , . . . % position on UI
480 ’ tag ’ , ’ rangeValue ’ , . . .
481 ’ BackgroundColor ’ ,[0.9 ,0.9 ,0.9]};
482
483 clear i j n sensx sensy rngx rngy prsx prsy
484
485 % Specify factor for converting sequenceRate to frameRate .
486 frameRateFactor = 5;
487 % Save all the structures to a .mat f i l e .
488 save ( ’L12 5_50mmImaging ’ ) ;Appendix 71
1 % File name SetUpL7_4Imaging .m:
2 % code for sending long pulses with imaging in between
3 % adapted from the Verasonic script SetUpL7_4FlashAngles .m
4 % LONG PULSES:
5 %   frequency : 4.09MHz
6 %   voltage : 100V
7 %   pulse length : 240us / idle time : 11us
8 %   train of pulses length : 5ms / idle time : 6s
9 % IMAGING:
10 %   frequency : 4.09MHz
11 %   voltage : 3V
12 %   pulse length 0.2 us
13 %   seven angles
14
15 clear all
16
17 % Specify system parameters .
18 Resource . Parameters . numTransmit = 128; % number of transmit channels .
19 Resource . Parameters . numRcvChannels = 128; % number of receive channels .
20 Resource . Parameters . speedOfSound = 1540;
21 Resource . Parameters . simulateMode = 0;
22 Resource . Parameters . fakeScanhead=1;
23
24 % Set imaging parameters
25 na = 7; % Set na = number of flash angles for 2D.
26 dtheta2D = (36* pi /180) /(na 1) ; % set dtheta2D to range over +/  18 degrees .
27
28 % Specify Trans structure array .
29 Trans .name = ’L7 4 ’ ;
30 Trans = computeTrans(Trans) ; % known transducers .
31 Trans . maxHighVoltage = 50;
32
33 % Specify SFormat structure array .
34 SFormat . transducer = ’L7 4 ’ ;
35 SFormat . scanFormat = ’RLIN ’ ; % rectangular linear array scan
36 SFormat . radius = 0;
37 SFormat . theta = 0;
38 SFormat .numRays = 1; % Flat Focus
39 SFormat . FirstRayLoc = [0 ,0 ,0]; % x ,y , z
40 SFormat . rayDelta = 128 *Trans . spacing ; % spacing dist . between rays ( wvlnghts )
41 SFormat . startDepth = 0; % Acquisition start depth in wavelengths
42 SFormat . endDepth = 150; % Acquisition end depth in wavelengths
43
44
45 % Specify PData structure array .
46 PData . sFormat = 1; % use f i r s t SFormat structure .
47 PData . pdeltaX = Trans . spacing ;
48 PData . pdeltaZ = 0.5;
49 PData . Size (1) = c e i l (( SFormat . endDepth  SFormat . startDepth )/PData . pdeltaZ ) ;
50 PData . Size (2) = c e i l (( Trans . numelements *Trans . spacing )/PData . pdeltaX ) ;
51 PData . Size (3) = 1; % single image page
52 PData . Origin = [  Trans . spacing *(Trans . numelements  1)/2 ,0 ,SFormat . startDepth ] ;
53
54 % only for simulation
55 % Specify Media object . ’ pt1 .m’ script defines array of point targets .
56 pt1 ;
57 Media . function = ’ movePoints ’ ;72 Appendix
58
59
60 % Specify Resources .
61 Resource . RcvBuffer (1) . datatype = ’ int16 ’ ;
62 Resource . RcvBuffer (1) . rowsPerFrame = 4096 *(na+1) ;
63 Resource . RcvBuffer (1) . colsPerFrame = Resource . Parameters . numRcvChannels ;
64 Resource . RcvBuffer (1) .numFrames = 235; % allows 5s of imaging
65 Resource . InterBuffer (1) . datatype = ’complex ’ ;
66 Resource . InterBuffer (1) .numFrames = 1; % one intermediate frame needed
67 Resource . InterBuffer (1) . rowsPerFrame = PData . Size (1) ;
68 Resource . InterBuffer (1) . colsPerFrame = PData . Size (2) ;
69 Resource . ImageBuffer (1) . datatype = ’ double ’ ; % image buffer for imaging
70 Resource . ImageBuffer (1) . rowsPerFrame = PData . Size (1) ;
71 Resource . ImageBuffer (1) . colsPerFrame = PData . Size (2) ;
72 Resource . ImageBuffer (1) .numFrames = 10;
73 Resource . DisplayWindow (1) . Title = ’Image Display ’ ;
74 Resource . DisplayWindow (1) . pdelta = 0.3;
75 Resource . DisplayWindow (1) . Position = [250 ,150 , . . .
76 c e i l (PData . Size (2) *PData . pdeltaX/Resource . DisplayWindow (1) . pdelta ) , . . . % width
77 c e i l (PData . Size (1) *PData . pdeltaZ/Resource . DisplayWindow (1) . pdelta ) ] ; % height
78 Resource . DisplayWindow (1) . ReferencePt = [ PData . Origin (1) ,PData . Origin (3) ] ;
79 Resource . DisplayWindow (1) . Colormap = gray (256) ;
80
81
82 % Specify Transmit waveform structures .
83 % for imaging
84 TW(1) . type = ’ parametric ’ ;
85 TW(1) . Parameters = [22 ,17 ,2 ,1]; % A=4.09MHz , B=77% duty cycle , C=0.2us , D=1
86 % for long pulses
87 TW(2) . type = ’ parametric ’ ;
88 TW(2) . Parameters = [22 ,8 ,31 ,1]; % A=4.09MHz , B=37% duty cycle , C=240us , D=1
89 TW(2) . extendBL = 1;
90
91
92 % Specify TX structure array .
93 TX = repmat( struct ( ’waveform ’ , 1 , . . .
94 ’ Origin ’ , [0.0 ,0.0 ,0.0] , . . .
95 ’ focus ’ , 0.0 , . . .
96 ’ Steer ’ , [0.0 ,0.0] , . . .
97 ’Apod ’ , ones (1 , Resource . Parameters . numTransmit) , . . .
98 ’ Delay ’ , zeros (1 , Resource . Parameters . numTransmit) ) , 1 , na+1) ;
99
100 %   Set event specific TX attributes .
101 i f fix (na/2) == na/2 % i f na even
102 startAngle = (  ( fix (na/2)   1)   0.5) *dtheta2D ;
103 else
104 startAngle =  fix (na/2) *dtheta2D ;
105 end
106 for n = 1: na % na transmit events for imaging
107 TX(n) . Steer = [( startAngle+(n  1)*dtheta2D) ,0.0];
108 TX(n) . Delay = computeTXDelays(TX(n) ) ;
109 end
110
111 TX(na+1) . waveform = 2;
112 TX(na+1) .Apod =[zeros (1 ,44) ones (1 ,40) zeros (1 ,44) ] ;
113 TX(na+1) . Delay = computeTXDelays(TX(n+1)) ;
114 TX(na+1) . focus =85; % 25mm
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116 % Specify TPC structures .
117 % for imaging
118 TPC(1) .name = ’2D’ ;
119 TPC(1) . maxHighVoltage = 50;
120 TPC(1) . highVoltageLimit = 50;
121 % for long pulses
122 TPC(5) .name = ’ long pulse ’ ;
123 TPC(5) . maxHighVoltage = 50;
124 TPC(5) . highVoltageLimit =50;
125
126
127 % Specify Receive structure arrays .
128 maxAcqLngth2D = sqrt (SFormat(1) . endDepth^2 + (Trans . numelements *Trans . spacing )^2)
  SFormat(1) . startDepth ;
129
130 wl4sPer128 = 128/(4 *2) ; % wavelengths in a 128 sample block for 4 smpls per wave
round trip .
131 wl2sPer128 = 128/(2 *2) ; % wavelengths in a 128 sample block for 2 smpls per wave
round trip .
132 Receive = repmat( struct ( ’Apod ’ , ones (1 , Resource . Parameters . numRcvChannels) , . . .
133 ’ startDepth ’ , SFormat(1) . startDepth , . . .
134 ’endDepth ’ , SFormat(1) . startDepth + wl4sPer128 * c e i l (maxAcqLngth2D/
wl4sPer128 ) , . . . ’TGC’ , 1 , . . .
135 ’bufnum ’ , 1 , . . .
136 ’framenum ’ , 1 , . . .
137 ’acqNum ’ , 1 , . . .
138 ’samplesPerWave ’ , 4 , . . . % samplesPerWave for 2D
139 ’mode ’ , 0 , . . .
140 ’ InputFilter ’ , [0.0036 ,0.0127 ,0.0066 ,  0.0881 ,  0.2595 ,0.6494] , . . .
’ callMediaFunc ’ , 1) , 1 , na *( Resource .
RcvBuffer (1) .numFrames) ) ;
141
142
143 %   Set event specific Receive attributes .
144 for i = 1: Resource . RcvBuffer (1) .numFrames
145 Receive (na *( i  1)+1) . callMediaFunc = 1;
146 for j = 1: na
147 Receive (na *( i  1)+j ) .Apod(1: Trans . numelements) = 1.0;
148 Receive (na *( i  1)+j ) . framenum = i ;
149 Receive (na *( i  1)+j ) .acqNum = j ;
150 end
151 end
152
153
154 % Specify TGC Waveform structures .
155 TGC(1) . CntrlPts = [400 ,500 ,625 ,700 ,750 ,800 ,850 ,950];
156 TGC(1) . rangeMax = SFormat(1) . endDepth ;
157 TGC(1) . Waveform = computeTGCWaveform(TGC(1) ) ;
158
159 % Specify Recon structure arrays .
160 Recon = struct ( ’ senscutoff ’ , 0.6 , . . .
161 ’pdatanum ’ , 1 , . . .
162 ’rcvBufFrame ’ ,  1, . . .
163 ’ IntBufDest ’ , [1 ,1] , . . .
164 ’ImgBufDest ’ , [1 ,  1] , . . .
165 ’RINums ’ ,(1: na+1)) ;
166
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168 % Define ReconInfo structures .
169 ReconInfo = repmat( struct ( ’mode ’ , 4 , . . . % default is to accumulate IQ data .
170 ’txnum ’ , 1 , . . .
171 ’rcvnum ’ , 1 , . . .
172 ’regionnum ’ , 0) , 1 , na+1) ;
173
174 % Set specific ReconInfo attributes .
175 ReconInfo (1) .mode = 3; % replace IQ data
176 for j = 1: na+1 % For each row in the column
177 ReconInfo ( j ) .txnum = j ;
178 ReconInfo ( j ) . rcvnum = j ;
179 end
180 ReconInfo (na+1) .mode = 5; % accum and detect
181
182 % Specify Process structure arrays .
183 cpt = 28; % define here so we can use in UIControl below persf = 80;
184 persp = 90;
185 DopState = ’ freq ’ ;
186 Process (1) . classname = ’Image ’ ;
187 Process (1) . method = ’ imageDisplay ’ ;
188 Process (1) . Parameters = { ’imgbufnum ’ , 1 , . . . % number of ImageBuffer to
process .
189 ’framenum ’ ,  1 ,... % frame number in source buffer (  1 =>
lastFrame )
190 ’pdatanum ’ , 1 , . . .
191 ’norm ’ , 1 , . . . % normalization method(1 means fixed )
192 ’ pgain ’ , 1 . 0 , . . . % pgain is image processing gain
193 ’ persistMethod ’ , ’ simple ’ , . . .
194 ’ persistLevel ’ ,20 ,...
195 ’ interp ’ , 1 , . . . % method of interpolation (1=4pt interp )
196 ’ compression ’ , 0 . 5 , . . . % X^0.5 normalized to output word size
197 ’ reject ’ , 2 , . . .
198 ’mappingMode ’ , ’ f u l l ’ , . . .
199 ’displayWindow ’ , 1 , . . .
200 ’ display ’ ,1}; % display image after processing
201
202
203 % Specify SeqControl structure arrays .
204
205 % Jump back to start .
206 SeqControl (1) .command = ’jump ’ ;
207 SeqControl (1) . argument = 1;
208 % Change to Profile 1
209 SeqControl (2) .command = ’ setTPCProfile ’ ;
210 SeqControl (2) . condition = ’ immediate ’ ;
211 SeqControl (2) . argument = 1;
212 % Change to Profile 5 ( long pulse )
213 SeqControl (3) .command = ’ setTPCProfile ’ ;
214 SeqControl (3) . condition = ’ immediate ’ ;
215 SeqControl (3) . argument = 5;
216 % Set to allow time for profile change .
217 SeqControl (4) .command = ’noop ’ ;
218 SeqControl (4) . argument = 8000; % time in us
219 % Time between long pulses
220 SeqControl (5) .command = ’timeToNextEB ’ ;
221 SeqControl (5) . argument = 251; % time in us
222 %1s not imaging and not transmitting long pulse
223 SeqControl (6) .command = ’timeToNextAcq ’ ;Appendix 75
224 SeqControl (6) . argument = 1000000; %1s
225 % return to MatLab
226 SeqControl (7) .command = ’ returnToMatlab ’ ;
227 % Time between 2D flash angle acquisitions
228 SeqControl (8) .command = ’timeToNextAcq ’ ;
229 SeqControl (8) . argument = 200; % time in us
230
231 % nsc is count of SeqControl objects
232 nsc = 9;
233
234 % n is count of Events
235 n = 1;
236
237 Event(n) . info = ’ set TPCProfile ’ ;
238 Event(n) . tx = 0; % no TX
239 Event(n) . rcv = 0; % no Rcv
240 Event(n) . recon = 0; % no Recon
241 Event(n) . process = 0;
242 Event(n) . seqControl = 2;
243 n=n+1;
244 for i = 1: Resource . RcvBuffer (1) .numFrames
245 i f i==Resource . RcvBuffer (1) .numFrames
246 Event(n) . info = ’ set TPCProfile ’ ;
247 Event(n) . tx=0;
248 Event(n) . rcv=0;
249 Event(n) . recon = 0; % no reconstruction .
250 Event(n) . process = 0; % no processing
251 Event(n) . seqControl =[3 ,4];
252 n=n+1;
253 for t= 1:20
254 Event(n) . info=’ Transmit long pulse ’ ;
255 Event(n) . tx=(na+1) ;
256 Event(n) . rcv=0;
257 Event(n) . recon = 0; % no reconstruction .
258 Event(n) . process = 0; % no processing
259 Event(n) . seqControl = 5;
260 n=n+1;
261 end
262 Event(n 1) . seqControl = 6;
263 Event(n) . info=’ return to Matlab ’ ;
264 Event(n) . tx=0;
265 Event(n) . rcv=0;
266 Event(n) . recon = 0; % no reconstruction .
267 Event(n) . process = 0; % no processing
268 Event(n) . seqControl = 7;
269 n=n+1;
270 else
271 % Acquire 2D frame
272 for j = 1: na
273 Event(n) . info = ’ Acquire 2D flash angle ’ ;
274 Event(n) . tx = j ; % use next TX structure .
275 Event(n) . rcv = na *( i  1)+j ;
276 Event(n) . recon = 0; % no reconstruction .
277 Event(n) . process = 0; % no processing
278 Event(n) . seqControl = 8; %
279 n = n+1;
280 end
281 Event(n 1) . seqControl = [ nsc , nsc +1]; % modify last acquisition Event ’ s76 Appendix
seqControl
282 SeqControl ( nsc ) .command = ’timeToNextAcq ’ ; % set time between frames
283 SeqControl ( nsc ) . argument = 20000; % 20000 usec = 20msec (~ 50 fps )
284 SeqControl ( nsc+1) .command = ’ transferToHost ’ ; % transfer frame to host buffer
285 nsc = nsc+2;
286 end
287 Event(n) . info = ’ recons and 2D process ’ ;
288 Event(n) . tx = 0; % no transmit
289 Event(n) . rcv = 0; % no rcv
290 Event(n) . recon = 1; % reconstruction
291 Event(n) . process = 1; % process 2D
292 Event(n) . seqControl = 0;
293 n = n+1;
294 i f floor ( i /3) == i /3
295 Event(n) . info = ’ return to MATLAB’ ;
296 Event(n) . tx = 0; % no transmit
297 Event(n) . rcv = 0; % no rcv
298 Event(n) . recon = 0; % reconstruction
299 Event(n) . process = 0; % Exit to Matlab every 3rd frame
300 Event(n) . seqControl = nsc ;
301 SeqControl ( nsc ) .command = ’ returnToMatlab ’ ;
302 nsc = nsc+1;
303 n = n+1;
304 end
305 end
306 Event(n) . info = ’Jump ’ ;
307 Event(n) . tx = 0; % no TX
308 Event(n) . rcv = 0; % no Rcv
309 Event(n) . recon = 0; % no Recon
310 Event(n) . process = 0;
311 Event(n) . seqControl = 1; % jump command
312 n=n+1;
313 Event(n) . info = ’FAKE’ ;
314 Event(n) . tx = 1; % no TX
315 Event(n) . rcv = 1; % no Rcv
316 Event(n) . recon = 0; % no Recon
317 Event(n) . process = 0;
318 Event(n) . seqControl = 0; % jump command
319 n=n+1;
320 Event(n) . info = ’FAKE’ ;
321 Event(n) . tx = 0; % no TX
322 Event(n) . rcv = 0; % no Rcv
323 Event(n) . recon = 0; % no Recon
324 Event(n) . process = 0;
325 Event(n) . seqControl = nsc ; % jump command
326 SeqControl ( nsc ) .command = ’ transferToHost ’ ;
327 nsc=nsc+1;
328
329
330 % User specified UI Control Elements
331 %   Sensitivity Cutoff
332 sensx = 170;
333 sensy = 420;
334 UI(1) . Control = { ’ Style ’ , ’ text ’ , . . . % popupmenu gives l i s t of choices
335 ’ String ’ , ’ Sens . Cutoff ’ , . . .
336 ’ Position ’ ,[ sensx+10,sensy ,100 ,20] ,... % position on UI
337 ’FontName ’ , ’ Arial ’ , ’FontWeight ’ , ’ bold ’ , ’ FontSize ’ ,12 ,...
338 ’ BackgroundColor ’ ,[0.8 ,0.8 ,0.8]};Appendix 77
339
340 UI(2) . Control = { ’ Style ’ , ’ slider ’ , . . . % popupmenu gives l i s t of choices
341 ’ Position ’ ,[ sensx , sensy  30 ,120 ,30] ,... % position on UI
342 ’Max’ ,1.0 , ’Min ’ ,0 , ’Value ’ ,Recon(1) . senscutoff , . . .
343 ’ SliderStep ’ ,[0.025 0 . 1 ] , . . .
344 ’Tag ’ , ’ sensSlider ’ , . . .
345 ’ Callback ’ ,{ @sensCutoffCallback }};
346
347 UI(2) . Callback = { ’ sensCutoffCallback .m’ , . . .
348 ’ function sensCutoffCallback (hObject , eventdata ) ’ , . . .
349 ’ ’ , . . .
350 ’ sens = get (hObject , ’ ’Value ’ ’ ) ; ’ , . . .
351 ’ReconL = evalin ( ’ ’ base ’ ’ , ’ ’Recon ’ ’ ) ; ’ , . . .
352 ’ for i = 1: size (ReconL ,2) ’ , . . .
353 ’ ReconL( i ) . senscutoff = sens ; ’ , . . .
354 ’end ’ , . . .
355 ’ assignin ( ’ ’ base ’ ’ , ’ ’Recon ’ ’ ,ReconL) ; ’ , . . .
356 ’% Set Control .Command to re  i n i t i a l i z e Recon structure . ’ , . . .
357 ’ Control = evalin ( ’ ’ base ’ ’ , ’ ’ Control ’ ’ ) ; ’ , . . .
358 ’ Control .Command = ’ ’ update&Run ’ ’ ; ’ , . . .
359 ’ Control . Parameters = { ’ ’Recon ’ ’ }; ’ , . . .
360 ’ assignin ( ’ ’ base ’ ’ , ’ ’ Control ’ ’ , Control ) ; ’ , . . .
361 ’% Set the new cutoff value in the text f i e l d . ’ , . . .
362 ’h = findobj ( ’ ’ tag ’ ’ , ’ ’ sensCutoffValue ’ ’ ) ; ’ , . . .
363 ’ set (h , ’ ’ String ’ ’ ,num2str( sens , ’ ’%1.3 f ’ ’ ) ) ; ’ , . . .
364 ’ return ’ };
365
366 UI(3) . Control = { ’ Style ’ , ’ edit ’ , ’ String ’ ,num2str(Recon(1) . senscutoff , ’%1.3 f ’ ) , . . .
%text
367 ’ Position ’ ,[ sensx+20,sensy  40 ,60 ,22] , . . . % position on UI
368 ’ tag ’ , ’ sensCutoffValue ’ , . . .
369 ’ BackgroundColor ’ , [ 0 . 9 , 0 . 9 , 0 . 9 ] , . . .
370 ’ Callback ’ ,{ @sensCutOffValueCallback }};
371
372 UI(3) . Callback = { ’ sensCutOffValueCallback .m’ , . . .
373 ’ function sensCutOffValueCallback (hObject , eventdata ) ’ , . . .
374 ’ ’ , . . .
375 ’ sens = str2num( get (hObject , ’ ’ String ’ ’ ) ) ; ’ , . . .
376 ’ReconL = evalin ( ’ ’ base ’ ’ , ’ ’Recon ’ ’ ) ; ’ , . . .
377 ’ for i = 1: size (ReconL ,2) ’ , . . .
378 ’ ReconL( i ) . senscutoff = sens ; ’ , . . .
379 ’end ’ , . . .
380 ’ assignin ( ’ ’ base ’ ’ , ’ ’Recon ’ ’ ,ReconL) ; ’ , . . .
381 ’% Set Control .Command to re  i n i t i a l i z e Recon structure . ’ , . . .
382 ’ Control = evalin ( ’ ’ base ’ ’ , ’ ’ Control ’ ’ ) ; ’ , . . .
383 ’ Control .Command = ’ ’ update&Run ’ ’ ; ’ , . . .
384 ’ Control . Parameters = { ’ ’Recon ’ ’ }; ’ , . . .
385 ’ assignin ( ’ ’ base ’ ’ , ’ ’ Control ’ ’ , Control ) ; ’ , . . .
386 ’% Set the new cutoff value for the slider ’ , . . .
387 ’ set ( findobj ( ’ ’Tag ’ ’ , ’ ’ sensSlider ’ ’ ) , ’ ’Value ’ ’ , sens ) ; ’ , . . .
388 ’ return ’ };
389
390 %   Range Change
391 rngx = 20;
392 rngy = 125;
393 UI(4) . Control = { ’ Style ’ , ’ text ’ , ’ String ’ , ’Range ’ , . . .
394 ’ Position ’ ,[ rngx+10,rngy , 8 0 , 2 0 ] , . . .
395 ’FontName ’ , ’ Arial ’ , ’FontWeight ’ , ’ bold ’ , ’ FontSize ’ ,12 ,...78 Appendix
396 ’ BackgroundColor ’ ,[0.8 ,0.8 ,0.8]};
397
398 UI(5) . Control = { ’ Style ’ , ’ slider ’ , . . .
399 ’ Position ’ ,[ rngx , rngy  30 ,120 ,30] ,...
400 ’Max’ ,320 , ’Min ’ ,64 , ’Value ’ ,SFormat . endDepth , . . .
401 ’ SliderStep ’ ,[0.125 ,0.250] ,...
402 ’ Callback ’ ,{ @rangeChangeCallback }};
403
404 UI(5) . Callback = { ’ rangeChangeCallback .m’ , . . .
405 ’ function rangeChangeCallback (hObject , eventdata ) ’ , . . .
406 ’ ’ , . . .
407 ’simMode = evalin ( ’ ’ base ’ ’ , ’ ’ Resource . Parameters . simulateMode ’ ’ ) ; ’ , . . .
408 ’% No range change i f in simulate mode 2. ’ , . . .
409 ’ i f simMode == 2 ’ , . . .
410 ’ set (hObject , ’ ’Value ’ ’ , evalin ( ’ ’ base ’ ’ , ’ ’SFormat . endDepth ’ ’ ) ) ; ’ , . . .
411 ’ return ’ , . . .
412 ’end ’ , . . .
413 ’ range = get (hObject , ’ ’Value ’ ’ ) ; ’ , . . .
414 ’ assignin ( ’ ’ base ’ ’ , ’ ’ range ’ ’ , range ) ; ’ , . . .
415 ’SFormat = evalin ( ’ ’ base ’ ’ , ’ ’SFormat ’ ’ ) ; ’ , . . .
416 ’SFormat . endDepth = range ; ’ , . . .
417 ’ assignin ( ’ ’ base ’ ’ , ’ ’SFormat ’ ’ ,SFormat) ; ’ , . . .
418 ’ evalin ( ’ ’ base ’ ’ , ’ ’PData . Size (1) =
419 c e i l (( SFormat . endDepth SFormat . startDepth )/PData . pdeltaZ ) ; ’ ’ ) ; ’ , . . .
420 ’ evalin ( ’ ’ base ’ ’ , ’ ’ [ PData . Region , PData . numRegions ] = createRegions (PData) ; ’ ’
) ; ’ , . . .
421 ’ evalin ( ’ ’ base ’ ’ , ’ ’ Resource . DisplayWindow (1) . Position (4) =
422 c e i l (PData . Size (1) *PData . pdeltaZ/Resource . DisplayWindow (1) . pdelta ) ; ’ ’ ) ; ’ , . . .
423 ’ Receive = evalin ( ’ ’ base ’ ’ , ’ ’ Receive ’ ’ ) ; ’ , . . .
424 ’Trans = evalin ( ’ ’ base ’ ’ , ’ ’Trans ’ ’ ) ; ’ , . . .
425 ’maxAcqLength = sqrt ( range^2 +
426 (Trans . numelements *Trans . spacing )^2) SFormat . startDepth ; ’ , . . .
427 ’ wlsPer128 = 128/(4 *2) ; ’ , . . .
428 ’ for i = 1: size ( Receive ,2) ’ , . . .
429 ’ Receive ( i ) . endDepth = SFormat . startDepth +
430 wlsPer128 * c e i l (maxAcqLength/wlsPer128 ) ; ’ , . . .
431 ’end ’ , . . .
432 ’ assignin ( ’ ’ base ’ ’ , ’ ’ Receive ’ ’ , Receive ) ; ’ , . . .
433 ’% Update VDAS parameters of Receive objects . ’ , . . .
434 ’ evalin ( ’ ’ base ’ ’ , ’ ’updateVDAS( ’ ’ ’ ’ Receive ’ ’ ’ ’ ) ’ ’ ) ; ’ , . . .
435 ’ evalin ( ’ ’ base ’ ’ , ’ ’TGC. rangeMax = SFormat . endDepth ; ’ ’ ) ; ’ , . . .
436 ’ evalin ( ’ ’ base ’ ’ , ’ ’TGC. Waveform = computeTGCWaveform(TGC) ; ’ ’ ) ; ’ , . . .
437 ’ Control = evalin ( ’ ’ base ’ ’ , ’ ’ Control ’ ’ ) ; ’ , . . .
438 ’ Control .Command = ’ ’ update&Run ’ ’ ; ’ , . . .
439 ’ Control . Parameters =
440 { ’ ’SFormat ’ ’ , ’ ’PData ’ ’ , ’ ’ Receive ’ ’ , ’ ’Recon ’ ’ , ’ ’DisplayWindow ’ ’ , ’ ’ ImageBuffer
’ ’ }; ’ , . . .
441 ’ assignin ( ’ ’ base ’ ’ , ’ ’ Control ’ ’ , Control ) ; ’ , . . .
442 ’ assignin ( ’ ’ base ’ ’ , ’ ’ action ’ ’ , ’ ’ displayChange ’ ’ ) ; ’ , . . .
443 ’h = findobj ( ’ ’ tag ’ ’ , ’ ’ rangeValue ’ ’ ) ; ’ , . . . ’ set (h , ’ ’
String ’ ’ ,num2str( range , ’ ’%3.0 f ’ ’ ) ) ; ’ , . . .
444 ’ return ’ };
445
446 UI(6) . Control = { ’ Style ’ , ’ edit ’ , ’ String ’ ,num2str(SFormat . endDepth , ’%3.0 f ’ ) , . . .%
text
447 ’ Position ’ ,[ rngx+20,rngy  40 ,60 ,22] , . . . % position on UI
448 ’ tag ’ , ’ rangeValue ’ , . . .
449 ’ BackgroundColor ’ ,[0.9 ,0.9 ,0.9]};Appendix 79
450
451 clear i j n sensx sensy rngx rngy
452 % Specify factor for converting sequenceRate to frameRate .
453 frameRateFactor = 5;
454 % Save all the structures to a .mat f i l e .
455 save ( ’L7 4Imaging ’ ) ;80 Appendix
1 % File name Control_tests .m:
2 % code for f i l t e r i n g the Control tests pressure data
3 % the code is equal for all the protocols ( only data are varying )
4
5 clear all
6 close all
7 clc
8
9 % T8 T4 and T10 are 12200x2 :
10 %f i r s t column pressure data
11 %second column zeros
12 T8=load ( ’ test8 . txt ’ ) ;
13 T4=load ( ’ test4 . txt ’ ) ;
14 T10=load ( ’ test3 . txt ’ ) ;
15
16
17 %moving average f i l t e r parameters
18 A=1;
19 B=ones (1 ,200) /200;
20
21 % create in second column the time vector ( equal for all )
22 i =1;
23 [ r , c]= size (T4) ;
24 tmax=r *0.1;
25 time=zeros (r ,1) ;
26 for j =0:0.1:tmax 1
27 time ( i )=j ;
28 i=i +1;
29 end
30 time (: ,1)=time (: ,1) /60; %convert to minutes
31
32 %apply f i l t e r
33 [ y4 , p4]= f i l t e r (B,A,T4(: ,1) ) ; % p4 final condition
34 y4=f i l t e r (B,A,T4(: ,1) ,p4 ) ; % p4 i n i t i a l condition
35 [ y8 , p8]= f i l t e r (B,A,T8(: ,1) ) ;
36 y8=f i l t e r (B,A,T8(: ,1) ,p8 ) ;
37 [ y10 , p10]= f i l t e r (B,A,T10(: ,1) ) ;
38 y10=f i l t e r (B,A,T10(: ,1) ,p10 ) ;
39
40 %save from sample 201
41 y1=y8(201:12200) ;
42 y2=y4(201:12200) ;
43 y3=y10 (201:12200) ;
44 t=time (1:12000) ;
45
46 %save in f i l e results Control
47 save ( ’ results_Control ’ , ’y1 ’ , ’y2 ’ , ’y3 ’ , ’ t ’ )Appendix 81
1 % File name Pressure_normalized .m:
2 % Code for normalized mean pressure plot for all protocols ( for Comparison)
3 clear all
4 close all
5 clc
6
7 % % control group
8 load ( ’ results_Control .mat ’ ) %contains f i l t e r e d data in y1 , y2 , y3
9 y1=y1+(100 y1 (1) ) ;
10 y2=y2+(100 y2 (1) ) ;
11 y3=y3+(100 y3 (1) ) ;
12
13 % % Protocol 1
14 load ( ’ results_protocol1 .mat ’ ) %contains f i l t e r e d data in y4 , y5 , y6
15 y4=y4+(100 y4 (1) ) ;
16 y5=y5+(100 y5 (1) ) ;
17 y6=y6+(100 y6 (1) ) ;
18
19 % % Protocol 2
20 load ( ’ results_protocol2 .mat ’ )
21 y7=y7+(100 y7 (1) ) ;
22 y8=y8+(100 y8 (1) ) ;
23 y9=y9+(100 y9 (1) ) ;
24
25 % % Protocol 3
26 load ( ’ results_protocol3 .mat ’ )
27 y10=y10+(100 y10 (1) ) ;
28 y11=y11+(100 y11 (1) ) ;
29 y12=y12+(100 y12 (1) ) ;
30
31 % % Protocol 4
32 load ( ’ results_SonoVue_50 ’ )
33 y13=y13+(100 y13 (1) ) ;
34 y14=y14+(100 y14 (1) ) ;
35 y15=y15+(100 y15 (1) ) ;
36
37 % % mean computation
38 control_test=[y1
39 y2
40 y3
41 ] ;
42 protocol1=[y4
43 y5
44 y6
45 ] ;
46 protocol2=[y7
47 y8
48 y9
49 ] ;
50 protocol3=[y10
51 y11
52 y12 ] ;
53 protocol4=[y13
54 y14
55 y15 ] ;
56
57 mean_control=zeros (12000 ,1) ;82 Appendix
58 for i =1:12000
59 tmp=0;
60 for j =1:3
61 tmp=tmp+control_test ( j , i ) ;
62 end
63 mean_control( i )=tmp/3;
64 clear tmp
65 end
66
67 mean_protocol1=zeros (12000 ,1) ;
68 for i =1:12000
69 tmp=0;
70 for j =1:3
71 tmp=tmp+protocol1 ( j , i ) ;
72 end
73 mean_protocol1( i )=tmp/3;
74 clear tmp
75 end
76
77 mean_protocol2=zeros (12000 ,1) ;
78 for i =1:12000
79 tmp=0;
80 for j =1:3
81 tmp=tmp+protocol2 ( j , i ) ;
82 end
83 mean_protocol2( i )=tmp/3;
84 clear tmp
85 end
86
87 mean_protocol3=zeros (12000 ,1) ;
88 for i =1:12000
89 tmp=0;
90 for j =1:3
91 tmp=tmp+protocol3 ( j , i ) ;
92 end
93 mean_protocol3( i )=tmp/3;
94 clear tmp
95 end
96
97 mean_protocol4=zeros (12000 ,1) ;
98 for i =1:12000
99 tmp=0;
100 for j =1:3
101 tmp=tmp+protocol4 ( j , i ) ;
102 end
103 mean_protocol4( i )=tmp/3;
104 clear tmp
105 end
106
107 figure (6)
108 plot (t , mean_control)
109 hold on
110 plot (t , mean_protocol1 , ’ r ’ )
111 hold on
112 plot (t , mean_protocol2 , ’g ’ )
113 hold on
114 plot (t , mean_protocol3 , ’m’ )
115 hold onAppendix 83
116 plot (t , mean_protocol4 , ’k ’ )
117 xlabel ( ’ time (min) ’ )
118 ylabel ( ’ pressure ’ )
119 legend ( ’ Control tests ’ , ’ Protocol 1 ’ , ’ Protocol 2 ’ , ’ Protocol 3 ’ , ’ Protocol 4 ’ )
120
121 sd1=std ( control_test (: ,600) ) ;
122 for i =1:20
123 hold on
124 sd=std ( control_test (: , i *600) ) ;
125 errorbar ( t ( i *600) ,mean_control( i *600) ,sd , ’x b ’ )
126 end
127 for i =1:20
128 hold on
129 sd=std ( protocol1 (: , i *600) ) ;
130 errorbar ( t ( i *600) , mean_protocol1( i *600) ,sd , ’o r ’ )
131 end
132 for i =1:20
133 hold on
134 sd=std ( protocol2 (: , i *600) ) ;
135 errorbar ( t ( i *600) , mean_protocol2( i *600) ,sd , ’ s g ’ )
136 end
137 for i =1:20
138 hold on
139 sd=std ( protocol3 (: , i *600) ) ;
140 errorbar ( t ( i *600) , mean_protocol3( i *600) ,sd , ’d m’ )
141 end
142 for i =1:20
143 hold on
144 sd=std ( protocol4 (: , i *600) ) ;
145 errorbar ( t ( i *600) , mean_protocol4( i *600) ,sd , ’ * k ’ )
146 end